Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:aldehydo-D-glucose
go back to main search page
Accession:CHEBI:42758 term browser browse the term
Definition:The open chain form of D-glucose.
Synonyms:exact_synonym: aldehydo-D-gluco-hexose
 related_synonym: (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal;   D-GLUCOSE IN LINEAR FORM;   D-glucose;   Dextrose;   Formula=C6H12O6;   Glucose;   InChI=1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1,3-6,8-12H,2H2/t3-,4+,5+,6+/m0/s1;   InChIKey=GZCGUPFRVQAUEE-SLPGGIOYSA-N;   SMILES=[H]C(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO;   WURCS=2.0/1,1,0/[o2122h]/1/
 alt_id: CHEBI:37625;   CHEBI:42756
 xref: Beilstein:1724615;   CAS:50-99-7;   DrugBank:DB01914;   GlyTouCan:G59743JO;   Gmelin:306224
 xref_mesh: MESH:D005947
 xref: PDBeChem:GLO;   Wikipedia:Glucose
 cyclic_relationship: is_enantiomer_of CHEBI:37626


show annotations for term's descendants           Sort by:
aldehydo-D-glucose term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PZP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of A2M mRNA CTD PMID:37567420 NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786 		JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 decreases expression
multiple interactions		 ISO Glucose results in decreased expression of ABCA1 mRNA; Glucose results in decreased expression of ABCA1 protein
morroniside inhibits the reaction [Glucose results in decreased expression of ABCA1 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of ABCA1 protein]		 CTD PMID:34485530 NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A decreases expression ISO Glucose results in decreased expression of ABCB1 protein CTD PMID:22363694 NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709 		JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ABCB4 mRNA CTD PMID:37567420 NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202 		JBrowse link
G Abcb7 ATP binding cassette subfamily B member 7 decreases expression ISO Glucose results in decreased expression of ABCB7 mRNA CTD PMID:17178593 NCBI chr  X:69,295,598...69,436,775
Ensembl chr  X:69,295,552...69,436,858 		JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 multiple interactions ISO Glucose inhibits the reaction [Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Daunorubicin]]; Glucose inhibits the reaction [Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Etoposide]] CTD PMID:10856430 NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions EXP [Benzbromarone results in decreased activity of ABCC2 protein] inhibits the reaction [Glucose results in increased secretion of S-(2,4-dinitrophenyl)glutathione]; [Furosemide results in increased activity of ABCC2 protein] promotes the reaction [Glucose results in increased secretion of S-(2,4-dinitrophenyl)glutathione]; [sulfanitran results in increased activity of ABCC2 protein] promotes the reaction [Glucose results in increased secretion of S-(2,4-dinitrophenyl)glutathione] CTD PMID:19782883 NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238 		JBrowse link
G Abcd2 ATP binding cassette subfamily D member 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ABCD2 mRNA CTD PMID:37567420 NCBI chr 7:122,263,034...122,311,642
Ensembl chr 7:122,263,032...122,311,642 		JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 decreases expression
multiple interactions		 ISO Glucose results in decreased expression of ABCG1 mRNA; Glucose results in decreased expression of ABCG1 protein
morroniside inhibits the reaction [Glucose results in decreased expression of ABCG1 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of ABCG1 protein]		 CTD PMID:34485530 NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948 		JBrowse link
G Acaca acetyl-CoA carboxylase alpha multiple interactions
decreases expression
increases expression
decreases phosphorylation		 ISO
EXP		 [INS protein co-treated with Glucose] results in increased expression of ACACA mRNA; [Pyruvic Acid co-treated with Glucose] results in increased phosphorylation of ACACA protein; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in decreased phosphorylation of ACACA protein]]; SIRT1 protein inhibits the reaction [Glucose results in decreased phosphorylation of ACACA protein]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of ACACA mRNA]
Glucose results in decreased expression of ACACA protein modified form
Glucose results in increased expression of ACACA mRNA		 CTD PMID:15066988 PMID:18482975 PMID:19071085 PMID:19724016 PMID:24349266 More... NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457 		JBrowse link
G Acacb acetyl-CoA carboxylase beta multiple interactions
decreases phosphorylation		 ISO 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [ACACB protein affects the reaction [Glucose results in decreased expression of PPARGC1A protein]]; 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide inhibits the reaction [ACACB protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]]; ACACB protein affects the reaction [Glucose results in decreased expression of NPHS1 protein]; ACACB protein affects the reaction [Glucose results in decreased expression of PPARGC1A protein]; ACACB protein affects the reaction [Glucose results in decreased expression of SIRT1 protein]; ACACB protein affects the reaction [Glucose results in decreased expression of SLC2A4 protein]; ACACB protein affects the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; ACACB protein affects the reaction [Glucose results in decreased phosphorylation of IRS1 protein]
Glucose results in decreased phosphorylation of ACACB protein		 CTD PMID:33957017 NCBI chr12:42,365,800...42,477,651
Ensembl chr12:42,366,548...42,457,655 		JBrowse link
G Acadl acyl-CoA dehydrogenase, long chain multiple interactions ISO [Glucose co-treated with Palmitic Acid] results in decreased expression of ACADL mRNA CTD PMID:39265716 NCBI chr 9:68,333,981...68,372,149
Ensembl chr 9:68,333,980...68,372,220 		JBrowse link
G Acadsb acyl-CoA dehydrogenase, short/branched chain multiple interactions ISO 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of ACADSB mRNA] CTD PMID:32613381 NCBI chr 1:186,188,939...186,227,796
Ensembl chr 1:186,188,987...186,230,379 		JBrowse link
G Ace angiotensin I converting enzyme increases expression
multiple interactions
decreases expression		 ISO
EXP		 Glucose results in increased expression of ACE protein
Enalaprilat inhibits the reaction [Glucose results in increased expression of ACE protein]
Glucose results in decreased expression of ACE mRNA
CEBPB protein inhibits the reaction [Glucose results in increased expression of ACE protein]
Glucose results in increased expression of ACE mRNA
NFE2L2 protein affects the reaction [Glucose results in increased expression of ACE mRNA]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in increased expression of ACE mRNA]]; trigonelline inhibits the reaction [Glucose results in increased expression of ACE mRNA]		 CTD PMID:16452552 PMID:29211853 PMID:29266779 PMID:31655124 NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131 		JBrowse link
G Ace2 angiotensin converting enzyme 2 multiple interactions
decreases expression		 EXP
ISO		 NFE2L2 protein affects the reaction [Glucose results in decreased expression of ACE2 mRNA]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in decreased expression of ACE2 mRNA]]; trigonelline inhibits the reaction [Glucose results in decreased expression of ACE2 mRNA]
CEBPB protein inhibits the reaction [Glucose results in decreased expression of ACE2 protein]; Glucose inhibits the reaction [CEBPB protein binds to ACE2 promoter]; Valsartan inhibits the reaction [Glucose results in decreased expression of ACE2 protein]		 CTD PMID:29211853 PMID:29266779 NCBI chr  X:30,293,597...30,340,961
Ensembl chr  X:30,293,589...30,340,977 		JBrowse link
G Ache acetylcholinesterase multiple interactions
decreases activity		 ISO Ascorbic Acid inhibits the reaction [Glucose results in decreased activity of ACHE protein] CTD PMID:26163454 NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651 		JBrowse link
G Acly ATP citrate lyase increases expression EXP
ISO		 Glucose results in increased expression of ACLY mRNA
Glucose deficiency results in increased expression of ACLY mRNA; Glucose deficiency results in increased expression of ACLY protein		 CTD PMID:24349266 PMID:26811028 NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320 		JBrowse link
G Aco1 aconitase 1 multiple interactions
increases expression		 EXP
ISO		 [Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein; Oxygen inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein]
Glucose results in increased expression of ACO1 protein		 CTD PMID:16135072 PMID:38483099 NCBI chr 5:55,259,841...55,315,872
Ensembl chr 5:55,259,827...55,316,391 		JBrowse link
G Aco2 aconitase 2 multiple interactions EXP [Glucose co-treated with Oxygen] affects the activity of ACO2 protein; Glucose results in decreased expression of and results in decreased activity of ACO2 protein; LONP1 protein affects the reaction [SRT1720 inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of ACO2 protein]]; manganese tetrakis-(N-ethyl-2 pyridyl) porphyrin inhibits the reaction [[Glucose co-treated with Oxygen] affects the activity of ACO2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[Glucose co-treated with Oxygen] affects the activity of ACO2 protein]; SRT1720 inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of ACO2 protein] CTD PMID:11520895 PMID:31639451 NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261 		JBrowse link
G Acot1 acyl-CoA thioesterase 1 increases expression
multiple interactions		 ISO Glucose results in increased expression of ACOT1 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ACOT1 mRNA		 CTD PMID:17178593 PMID:37567420 NCBI chr 6:103,636,173...103,644,167
Ensembl chr 6:103,636,041...103,644,163 		JBrowse link
G Acox1 acyl-CoA oxidase 1 increases expression
decreases expression
multiple interactions		 ISO Glucose results in increased expression of ACOX1 mRNA
Glucose results in decreased expression of ACOX1 protein
[Glucose co-treated with Palmitic Acid] results in decreased expression of ACOX1 mRNA; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of ACOX1 protein]]]]; Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of ACOX1 protein]; jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of ACOX1 protein]]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of ACOX1 protein]]]		 CTD PMID:36156098 PMID:39059604 PMID:39265716 NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232 		JBrowse link
G Acox2 acyl-CoA oxidase 2 decreases expression ISO Glucose results in decreased expression of ACOX2 mRNA CTD PMID:17178593 NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160 		JBrowse link
G Acsbg1 acyl-CoA synthetase bubblegum family member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of ACSBG1 mRNA CTD PMID:37567420 NCBI chr 8:54,991,294...55,047,276
Ensembl chr 8:54,991,296...55,047,391 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 multiple interactions ISO [Glucose co-treated with Palmitic Acid] results in decreased expression of ACSL1 mRNA CTD PMID:39265716 NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541 		JBrowse link
G Acsl4 acyl-CoA synthetase long-chain family member 4 multiple interactions EXP [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ACSL4 protein; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ACSL4 protein] CTD PMID:36806343 NCBI chr  X:105,942,794...106,006,573
Ensembl chr  X:105,942,799...106,006,427 		JBrowse link
G Acsm2 acyl-CoA synthetase medium-chain family member 2 increases expression ISO Glucose results in increased expression of ACSM2 mRNA CTD PMID:31525975 NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116 		JBrowse link
G Acsm3 acyl-CoA synthetase medium-chain family member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ACSM3 mRNA CTD PMID:37567420 NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184 		JBrowse link
G Acss1 acyl-CoA synthetase short-chain family member 1 increases expression ISO Glucose results in increased expression of ACSS1 mRNA CTD PMID:36156098 NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325 		JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 increases expression ISO Glucose results in increased expression of ACSS2 mRNA CTD PMID:36156098 NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675 		JBrowse link
G Acta1 actin, alpha 1, skeletal muscle increases expression
multiple interactions
decreases expression		 EXP
ISO		 Glucose results in increased expression of ACTA1 mRNA
HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]; Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased expression of ACTA1 mRNA]]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ACTA1 mRNA; fucoxanthin inhibits the reaction [Glucose results in decreased expression of ACTA1 mRNA]		 CTD PMID:24810525 PMID:33448797 PMID:37567420 NCBI chr19:51,883,709...51,886,735
Ensembl chr19:51,883,715...51,886,742 		JBrowse link
G Acta2 actin alpha 2, smooth muscle multiple interactions
increases expression		 ISO
EXP		 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in increased expression of ACTA2 protein]; [Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in increased expression of ACTA2 protein]; MAPK14 protein promotes the reaction [Glucose results in increased expression of ACTA2 protein]
Glucose results in increased expression of ACTA2 mRNA; Glucose results in increased expression of ACTA2 protein
cinnamaldehyde inhibits the reaction [Glucose results in increased expression of ACTA2 protein]		 CTD PMID:20060012 PMID:21829520 PMID:26045780 PMID:29163160 PMID:35961541 NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554 		JBrowse link
G Actb actin, beta decreases expression ISO Glucose deficiency results in decreased expression of ACTB protein CTD PMID:22314686 NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877 		JBrowse link
G Actg1 actin, gamma 1 multiple interactions EXP ACTG1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr10:105,619,738...105,622,587
Ensembl chr10:105,619,737...105,624,232
Ensembl chr 3:105,619,737...105,624,232 		JBrowse link
G Actr2 actin related protein 2 multiple interactions
decreases expression		 ISO Eucalyptol inhibits the reaction [Glucose results in decreased expression of ACTR2 protein] CTD PMID:31483951 NCBI chr14:94,296,443...94,333,735
Ensembl chr14:94,296,443...94,340,524 		JBrowse link
G Adam17 ADAM metallopeptidase domain 17 decreases expression ISO Glucose results in decreased expression of ADAM17 mRNA CTD PMID:31655124 NCBI chr 6:40,872,936...40,920,700
Ensembl chr 6:40,872,856...40,920,639 		JBrowse link
G Adam19 ADAM metallopeptidase domain 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of ADAM19 mRNA CTD PMID:37567420 NCBI chr10:30,491,362...30,583,115
Ensembl chr10:30,491,405...30,583,105 		JBrowse link
G Adam32 ADAM metallopeptidase domain 32 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ADAM32 mRNA CTD PMID:37567420 NCBI chr16:67,102,384...67,212,163
Ensembl chr16:67,102,320...67,212,161 		JBrowse link
G Adam7 ADAM metallopeptidase domain 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of ADAM7 mRNA CTD PMID:37567420 NCBI chr15:42,833,796...42,882,201
Ensembl chr15:42,833,796...42,882,201 		JBrowse link
G Adam8 ADAM metallopeptidase domain 8 increases expression
multiple interactions		 ISO Glucose results in increased expression of ADAM8 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADAM8 mRNA		 CTD PMID:17178593 PMID:37567420 NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 increases expression ISO Glucose results in increased expression of ADAMTS1 mRNA CTD PMID:17178593 NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103 		JBrowse link
G Adcy7 adenylate cyclase 7 decreases methylation
multiple interactions
increases expression		 ISO Glucose results in decreased methylation of ADCY7 gene
fucoxanthin inhibits the reaction [Glucose results in decreased methylation of ADCY7 gene]; fucoxanthin inhibits the reaction [Glucose results in increased expression of ADCY7 mRNA]		 CTD PMID:33448797 NCBI chr19:18,740,875...18,798,924
Ensembl chr19:18,740,875...18,776,311 		JBrowse link
G Adgra1 adhesion G protein-coupled receptor A1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRA1 mRNA CTD PMID:37567420 NCBI chr 1:194,629,744...194,673,254
Ensembl chr 1:194,629,726...194,672,550 		JBrowse link
G Adgrb1 adhesion G protein-coupled receptor B1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRB1 mRNA CTD PMID:37567420 NCBI chr 7:106,404,827...106,476,902
Ensembl chr 7:106,404,958...106,476,902 		JBrowse link
G Adgre4 adhesion G protein-coupled receptor E4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADGRE4 mRNA CTD PMID:37567420 NCBI chr 9:9,758,106...9,901,908
Ensembl chr 9:9,760,355...9,900,760 		JBrowse link
G Adgrf4 adhesion G protein-coupled receptor F4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ADGRF4 mRNA CTD PMID:37567420 NCBI chr 9:18,272,050...18,303,219
Ensembl chr 9:18,272,050...18,303,217 		JBrowse link
G Adgrg4 adhesion G protein-coupled receptor G4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ADGRG4 mRNA CTD PMID:37567420 NCBI chr  X:134,734,610...134,864,449
Ensembl chr  X:134,854,736...134,864,449 		JBrowse link
G Adhfe1 alcohol dehydrogenase, iron containing, 1 decreases expression ISO Glucose results in decreased expression of ADHFE1 mRNA CTD PMID:17178593 NCBI chr 5:9,705,966...9,732,580
Ensembl chr 5:9,705,970...9,732,517 		JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing decreases expression
increases expression
multiple interactions
increases secretion		 EXP
ISO		 Glucose results in decreased expression of ADIPOQ protein
Glucose results in increased expression of ADIPOQ protein
[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; [Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; butylbenzyl phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; Diethylhexyl Phthalate promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; Pioglitazone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]; tributyltin promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ protein]
Glucose deficiency results in increased secretion of ADIPOQ protein
ADIPOQ protein inhibits the reaction [Glucose results in decreased expression of ADIPOR2 protein]; argan oil promotes the reaction [Glucose results in increased expression of ADIPOQ protein]; Corn Oil promotes the reaction [Glucose results in increased expression of ADIPOQ protein]		 CTD PMID:21912612 PMID:24802182 PMID:29165388 PMID:32407875 NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564 		JBrowse link
G Adipor1 adiponectin receptor 1 multiple interactions
decreases expression		 EXP FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]; FOXO1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]]; FOXO1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]]; Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; Resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]
Glucose results in decreased expression of ADIPOR1 mRNA; Glucose results in decreased expression of ADIPOR1 protein		 CTD PMID:24413998 NCBI chr13:45,859,461...45,879,248
Ensembl chr13:45,859,533...45,879,241 		JBrowse link
G Adipor2 adiponectin receptor 2 multiple interactions
decreases expression		 EXP ADIPOQ protein inhibits the reaction [Glucose results in decreased expression of ADIPOR2 protein] CTD PMID:21912612 NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355 		JBrowse link
G Adra1a adrenoceptor alpha 1A multiple interactions EXP 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 2-(1-(3-dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1H-indol-3-yl)maleimide inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose]; [cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose; [Phenylephrine results in increased activity of ADRA1A protein] which results in increased transport of Glucose; Prazosin inhibits the reaction [[cirazoline results in increased activity of ADRA1A protein] which results in increased transport of Glucose] CTD PMID:15550506 NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500 		JBrowse link
G Adrb2 adrenoceptor beta 2 multiple interactions ISO [BRL 37344 binds to and results in increased activity of ADRB2 protein] which results in increased uptake of Glucose; [Clenbuterol binds to and results in increased activity of ADRB2 protein] which results in decreased uptake of Glucose; ICI 118551 inhibits the reaction [[BRL 37344 binds to and results in increased activity of ADRB2 protein] which results in increased uptake of Glucose]; ICI 118551 inhibits the reaction [[Clenbuterol binds to and results in increased activity of ADRB2 protein] which results in decreased uptake of Glucose] CTD PMID:18552870 NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512 		JBrowse link
G Adrb3 adrenoceptor beta 3 multiple interactions ISO [BRL 37344 binds to and results in increased activity of ADRB3 protein] which results in decreased abundance of Glucose; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ADRB3 mRNA CTD PMID:20930473 PMID:37567420 NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552 		JBrowse link
G Afp alpha-fetoprotein increases expression ISO Glucose results in increased expression of AFP mRNA CTD PMID:17178593 NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480 		JBrowse link
G Agbl4 AGBL carboxypeptidase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of AGBL4 mRNA CTD PMID:37567420 NCBI chr 5:125,254,963...126,534,367
Ensembl chr 5:125,254,956...126,534,367 		JBrowse link
G Ager advanced glycosylation end product-specific receptor multiple interactions
increases expression		 ISO
EXP		 GLO1 inhibits the reaction [Glucose promotes the reaction [RELA protein binds to AGER promoter]]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER protein]; Glucose promotes the reaction [RELA protein binds to AGER promoter]; Luteolin inhibits the reaction [Glucose results in increased expression of AGER mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of AGER mRNA]; RELA promotes the reaction [Glucose results in increased expression of AGER mRNA]; Rutin inhibits the reaction [Glucose results in increased expression of AGER mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; SOD2 inhibits the reaction [Glucose results in increased expression of AGER protein]; UCP1 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; UCP1 inhibits the reaction [Glucose results in increased expression of AGER protein]
[Ribose co-treated with Glucose] results in increased expression of AGER protein; AGER protein affects the reaction [Ribose promotes the reaction [Glucose results in increased phosphorylation of RELA protein]]
Glucose results in increased expression of AGER mRNA; Glucose results in increased expression of AGER protein
AGER protein results in increased susceptibility to [Azoxymethane co-treated with Glucose co-treated with Linoleic Acid]; Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]; Glucose promotes the reaction [Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]]; Linoleic Acid promotes the reaction [Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]]; Losartan inhibits the reaction [Glucose promotes the reaction [Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]; Losartan inhibits the reaction [Linoleic Acid promotes the reaction [Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]; Metformin inhibits the reaction [Glucose promotes the reaction [Linoleic Acid promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]; Metformin inhibits the reaction [Linoleic Acid promotes the reaction [Glucose promotes the reaction [Azoxymethane results in increased expression of AGER protein]]]		 CTD PMID:19557821 PMID:19759273 PMID:19833897 PMID:22467055 PMID:30101366 NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078 		JBrowse link
G Agl amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase increases uptake ISO AGL protein results in increased uptake of Glucose CTD PMID:24700805 NCBI chr 2:204,705,053...204,760,966
Ensembl chr 2:204,705,053...204,760,828 		JBrowse link
G Agt angiotensinogen multiple interactions
increases expression
affects metabolic processing		 ISO
EXP		 (3,4-dihydroxyphenylamino)-2-imidazoline inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]; [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]]; acetovanillone inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; Enalaprilat inhibits the reaction [Glucose results in increased expression of AGT protein]; Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of FOSL1 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of KLF10 mRNA]; Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]; Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]; Rotenone inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]; Simvastatin promotes the reaction [Glucose promotes the reaction [AGT protein results in increased expression of PTGS2 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of KLF10 mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of LIF mRNA]]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased phosphorylation of JAK2 protein]]
1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Glucose results in increased expression of AGT mRNA]; 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [Glucose results in increased expression of AGT protein]; alpha-cyano-4-hydroxycinnamate inhibits the reaction [Glucose results in increased expression of AGT mRNA]; alpha-cyano-4-hydroxycinnamate inhibits the reaction [Glucose results in increased expression of AGT protein]; Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Carbonyl Cyanide m-Chlorophenyl Hydrazone inhibits the reaction [Glucose results in increased expression of AGT protein]; CAT protein inhibits the reaction [Glucose results in increased expression of AGT mRNA]; CAT protein inhibits the reaction [Glucose results in increased expression of AGT protein]; Hydrogen Peroxide promotes the reaction [Glucose results in increased expression of AGT mRNA]; Hydrogen Peroxide promotes the reaction [Glucose results in increased expression of AGT protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of AGT mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of AGT protein]; NFE2L2 protein affects the reaction [Glucose results in increased expression of AGT mRNA]; oltipraz inhibits the reaction [trigonelline inhibits the reaction [Glucose results in increased expression of AGT mRNA]]; Rotenone inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Rotenone inhibits the reaction [Glucose results in increased expression of AGT protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of AGT mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of AGT protein]; Taurine inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Taurine inhibits the reaction [Glucose results in increased expression of AGT protein]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Thenoyltrifluoroacetone inhibits the reaction [Glucose results in increased expression of AGT protein]; trigonelline inhibits the reaction [Glucose results in increased expression of AGT mRNA]; Valsartan promotes the reaction [Glucose results in increased expression of AGT protein]
AGT protein affects the metabolism of Glucose
Glucose results in increased expression of AGT mRNA; Glucose results in increased expression of AGT protein		 CTD PMID:11115780 PMID:12130563 PMID:15677497 PMID:16452552 PMID:19225232 More... NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977 		JBrowse link
G Agtr1a angiotensin II receptor, type 1a increases expression
multiple interactions		 ISO Glucose results in increased expression of AGTR1 mRNA; Glucose results in increased expression of AGTR1 protein
Enalaprilat inhibits the reaction [Glucose results in increased expression of AGTR1 protein]
CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR1 protein]		 CTD PMID:16452552 PMID:29266779 PMID:31655124 PMID:34464088 NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946 		JBrowse link
G Agtr2 angiotensin II receptor, type 2 multiple interactions
increases expression		 ISO CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR2 protein] CTD PMID:29266779 NCBI chr  X:112,119,876...112,124,060
Ensembl chr  X:112,120,228...112,124,057 		JBrowse link
G Ahr aryl hydrocarbon receptor multiple interactions
increases response to substance		 ISO 4,7-phenanthroline inhibits the reaction [AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]]; AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]; alpha-naphthoflavone inhibits the reaction [AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]]
AHR protein promotes the reaction [Tetrachlorodibenzodioxin affects the susceptibility to Glucose]
AHR results in increased susceptibility to Glucose		 CTD PMID:8738555 PMID:19623578 PMID:21849270 NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568 		JBrowse link
G Aif1 allograft inflammatory factor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of AIF1 mRNA CTD PMID:37567420 NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668 		JBrowse link
G Aifm1 apoptosis inducing factor, mitochondria associated 1 affects localization
multiple interactions		 EXP Glucose affects the localization of AIFM1 protein
Quercetin affects the reaction [Glucose affects the localization of AIFM1 protein]; sesamin affects the reaction [Glucose affects the localization of AIFM1 protein]		 CTD PMID:19146853 PMID:22524206 NCBI chr  X:127,650,223...127,689,356
Ensembl chr  X:127,650,226...127,689,256 		JBrowse link
G Ak8 adenylate kinase 8 increases expression
multiple interactions		 ISO Glucose results in increased expression of AK8 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of AK8 mRNA]		 CTD PMID:33448797 NCBI chr 3:12,028,895...12,144,468
Ensembl chr 3:12,028,954...12,144,465 		JBrowse link
G Akap5 A-kinase anchoring protein 5 increases expression ISO Glucose results in increased expression of AKAP5 mRNA CTD PMID:31525975 NCBI chr 6:95,051,527...95,061,075
Ensembl chr 6:95,051,537...95,061,578 		JBrowse link
G Akr1a1 aldo-keto reductase family 1 member A1 multiple interactions
decreases expression		 ISO fidarestat inhibits the reaction [Glucose results in decreased expression of AKR1A1 mRNA] CTD PMID:16805838 NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B1 multiple interactions
increases expression		 ISO AKR1B1 protein promotes the reaction [Glucose results in increased abundance of Sorbitol]
Glucose results in increased expression of AKR1B1 mRNA; Glucose results in increased expression of AKR1B1 protein		 CTD PMID:16805838 PMID:25451566 NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157 		JBrowse link
G Akr1c1 aldo-keto reductase family 1, member C1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of AKR1C6 mRNA CTD PMID:37567420 NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of AKR1C18 mRNA CTD PMID:37567420 NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases phosphorylation
multiple interactions
increases response to substance
decreases expression
decreases phosphorylation
increases expression		 ISO
EXP		 Glucose results in increased phosphorylation of AKT1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; [Glucose affects the susceptibility to INS protein] which affects the phosphorylation of AKT1 protein; [Palmitic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein; ACACB protein affects the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; albiflorin inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein]; Berberine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Captopril inhibits the reaction [Glucose results in increased expression of AKT1 mRNA]; Fluorometholone inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Glucose inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]; HAGLR protein affects the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; HAGLR protein inhibits the reaction [MIR106B inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; huai qi huang inhibits the reaction [Glucose results in increased expression of AKT1 mRNA]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; MIR106B inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose inhibits the reaction [INS protein results in increased phosphorylation of AKT1 protein]]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; spiraeoside inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; zhenwu decoction inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein]
AKT1 protein mutant form results in increased susceptibility to Glucose deficiency
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Glucose co-treated with Calcitriol] results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency] which results in increased phosphorylation of EIF4EBP1 protein; [Glucose co-treated with Calcitriol] results in increased phosphorylation of AKT1 protein; AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency]; AKT1 protein modified form inhibits the reaction [arsenite inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; AKT1 protein modified form inhibits the reaction [monomethylarsonous acid inhibits the reaction [INS1 protein results in increased uptake of Glucose]]; AKT1 protein promotes the reaction [Glucose affects the phosphorylation of and affects the activity of FOXO3 protein]; Bezafibrate inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency]; Glucose affects the phosphorylation of and affects the activity of AKT1 protein; methyl pyruvate inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency]; PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]]; SMARCA4A protein inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]
Glucose results in decreased expression of AKT1 protein modified form
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [deuterohemin-alanyl-histidyl-threonyl-valyl-glutamyl-lysine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [diallyl trisulfide inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]; 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; [3,4-Dihydroxyphenylacetic Acid co-treated with Glucose] results in increased phosphorylation of AKT1 protein; [Catechin co-treated with Glucose] results in increased phosphorylation of AKT1 protein; [Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein; Acetylcysteine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; deuterohemin-alanyl-histidyl-threonyl-valyl-glutamyl-lysine inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; diallyl trisulfide inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of AKT1 protein]; Resveratrol inhibits the reaction [Glucose results in increased phosphorylation of AKT1 protein]; Simvastatin inhibits the reaction [Glucose results in decreased expression of AKT1 protein modified form]		 CTD PMID:15806154 PMID:16385087 PMID:17520061 PMID:18004065 PMID:20370652 More... NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Akt2 AKT serine/threonine kinase 2 affects response to substance ISO AKT2 protein affects the susceptibility to Glucose CTD PMID:21964073 NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817 		JBrowse link
G Alb albumin multiple interactions
increases metabolic processing
decreases uptake		 ISO
EXP		 [Fructose co-treated with Glucose] results in increased glycation of ALB protein; [Peroxynitrous Acid co-treated with Glucose] results in increased glycation of ALB protein; Phlorhizin inhibits the reaction [Glucose results in decreased uptake of ALB protein]; pimagedine inhibits the reaction [[Fructose co-treated with Glucose] results in increased glycation of ALB protein]; pimagedine inhibits the reaction [[Peroxynitrous Acid co-treated with Glucose] results in increased glycation of ALB protein]; ursonic acid inhibits the reaction [[Fructose co-treated with Glucose] results in increased glycation of ALB protein]
Glucose results in increased metabolism of ALB protein
[Glucose deficiency co-treated with ALB protein] results in decreased expression of FABP4 mRNA; [Glucose deficiency co-treated with ALB protein] results in decreased expression of PCK1 mRNA
ALB protein modified form inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]; ALB protein modified form inhibits the reaction [Glucose results in increased secretion of INS1 protein]; MK615 extract inhibits the reaction [ALB protein modified form inhibits the reaction [Glucose results in increased phosphorylation of RELA protein]]; MK615 extract inhibits the reaction [ALB protein modified form inhibits the reaction [Glucose results in increased secretion of INS1 protein]]		 CTD PMID:8536680 PMID:12196478 PMID:12434198 PMID:16313995 PMID:27415824 More... NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836 		JBrowse link
G Alcam activated leukocyte cell adhesion molecule multiple interactions
increases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of ALCAM mRNA] CTD PMID:33448797 NCBI chr11:48,336,123...48,536,296
Ensembl chr11:48,336,169...48,537,954 		JBrowse link
G Aldh1b1 aldehyde dehydrogenase 1 family, member B1 increases expression ISO Glucose deficiency results in increased expression of ALDH1B1 protein CTD PMID:22314686 NCBI chr 5:60,063,370...60,068,378
Ensembl chr 5:60,063,225...60,068,378 		JBrowse link
G Aldh1l2 aldehyde dehydrogenase 1 family, member L2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of ALDH1L2 mRNA CTD PMID:37567420 NCBI chr 7:20,254,246...20,305,793
Ensembl chr 7:20,254,233...20,305,776 		JBrowse link
G Aldh2 aldehyde dehydrogenase 2 family member decreases expression
multiple interactions		 EXP Glucose results in decreased expression of ALDH2 protein
N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ALDH2 protein]		 CTD PMID:29128638 NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521 		JBrowse link
G Aldh3b3 aldehyde dehydrogenase 3 family, member B3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ALDH3B3 mRNA CTD PMID:37567420 NCBI chr 1:201,193,832...201,201,666
Ensembl chr 1:201,187,962...201,250,204 		JBrowse link
G Aldh6a1 aldehyde dehydrogenase 6 family, member A1 decreases expression ISO Glucose results in decreased expression of ALDH6A1 mRNA CTD PMID:17178593 NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656 		JBrowse link
G Alg12 ALG12, alpha-1,6-mannosyltransferase decreases expression ISO Glucose results in decreased expression of ALG12 mRNA CTD PMID:17178593 NCBI chr 7:119,895,112...119,909,488
Ensembl chr 7:119,895,120...119,909,458 		JBrowse link
G Alk ALK receptor tyrosine kinase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ALK mRNA CTD PMID:37567420 NCBI chr 6:22,879,653...23,599,636
Ensembl chr 6:22,880,625...23,598,034 		JBrowse link
G Alox12 arachidonate 12-lipoxygenase, 12S type increases expression ISO Glucose results in increased expression of ALOX12 mRNA CTD PMID:32942007 NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase multiple interactions
increases expression		 EXP
ISO		 [Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein; caffeic acid inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein]; Edaravone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein]; SB 203580 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein]
Glucose results in increased expression of ALOX5 mRNA		 CTD PMID:18951527 PMID:31655124 NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743 		JBrowse link
G Alpk3 alpha-kinase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ALPK3 mRNA CTD PMID:37567420 NCBI chr 1:135,014,455...135,062,294
Ensembl chr 1:135,014,499...135,062,302 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated decreases expression
multiple interactions		 ISO
EXP		 Glucose results in decreased expression of ALPL mRNA
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL protein]]; Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]]
morroniside inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]		 CTD PMID:32643284 PMID:33450223 NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446 		JBrowse link
G Amer2 APC membrane recruitment protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of AMER2 mRNA CTD PMID:37567420 NCBI chr15:34,525,352...34,535,660
Ensembl chr15:34,524,542...34,528,455 		JBrowse link
G Amot angiomotin decreases expression ISO Glucose results in decreased expression of AMOT mRNA CTD PMID:17178593 NCBI chr  X:108,982,399...109,041,265
Ensembl chr  X:108,984,022...109,041,272 		JBrowse link
G Angptl4 angiopoietin-like 4 increases expression ISO Glucose results in increased expression of ANGPTL4 mRNA CTD PMID:16805838 NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519 		JBrowse link
G Ankrd61 ankyrin repeat domain 61 decreases expression
multiple interactions		 ISO Glucose results in decreased expression of ANKRD61 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ANKRD61 mRNA]		 CTD PMID:31525975 PMID:33448797 NCBI chr12:10,718,908...10,723,267
Ensembl chr12:10,718,908...10,723,265 		JBrowse link
G Anks1b ankyrin repeat and sterile alpha motif domain containing 1B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ANKS1B mRNA CTD PMID:37567420 NCBI chr 7:24,313,339...25,479,307
Ensembl chr 7:24,312,843...25,477,693 		JBrowse link
G Anxa5 annexin A5 decreases expression ISO Glucose results in decreased expression of ANXA5 mRNA CTD PMID:31655124 NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369 		JBrowse link
G Aoc1 amine oxidase, copper containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of AOC1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of AOC1 mRNA CTD PMID:37567420 NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840 		JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of APAF1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of APAF1 mRNA] CTD PMID:33962019 NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540 		JBrowse link
G Apc APC regulator of WNT signaling pathway decreases expression EXP Glucose results in decreased expression of APC mRNA CTD PMID:21818840 NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696 		JBrowse link
G Apcs amyloid P component, serum multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of APCS mRNA CTD PMID:37567420 NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298 		JBrowse link
G Apoa1 apolipoprotein A1 increases expression
decreases expression		 EXP Glucose results in increased expression of APOA1 mRNA; Glucose results in increased expression of APOA1 protein
Glucose results in decreased expression of APOA1 mRNA		 CTD PMID:9322794 PMID:9668074 NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035 		JBrowse link
G Apob apolipoprotein B multiple interactions ISO Glucose promotes the reaction [Copper Sulfate results in increased cleavage of APOB protein] CTD PMID:19489629 NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497 		JBrowse link
G Apoe apolipoprotein E affects secretion
multiple interactions
decreases expression		 ISO Glucose deficiency affects the secretion of APOE protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of APOE mRNA; morroniside inhibits the reaction [Glucose results in decreased expression of APOE mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of APOE protein]
Glucose results in decreased expression of APOE mRNA; Glucose results in decreased expression of APOE protein		 CTD PMID:24802182 PMID:34485530 PMID:37567420 NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932 		JBrowse link
G Apol9a apolipoprotein L9a multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of APOL9A mRNA CTD PMID:37567420 NCBI chr 7:109,140,871...109,149,799
Ensembl chr 7:109,140,871...109,147,649 		JBrowse link
G App amyloid beta precursor protein multiple interactions
increases abundance		 ISO [APP protein mutant form co-treated with PSEN1 protein mutant form co-treated with PF-06840003] results in decreased abundance of Glucose; [APP protein mutant form co-treated with PSEN1 protein mutant form] results in increased abundance of Glucose; IDO1 protein affects the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in increased abundance of Glucose]
PF-06840003 inhibits the reaction [APP protein mutant form results in increased abundance of Glucose]		 CTD PMID:39172838 NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561 		JBrowse link
G Aqp1 aquaporin 1 increases expression
multiple interactions		 EXP Glucose results in increased expression of AQP1 mRNA
benazepril inhibits the reaction [Glucose results in increased expression of AQP1 mRNA]; valsartan inhibits the reaction [Glucose results in increased expression of AQP1 mRNA]		 CTD PMID:11510275 NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690 		JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) multiple interactions
increases expression		 ISO Glucose promotes the reaction [AQP3 protein results in increased transport of Glycerol]
Glucose results in increased expression of AQP3 mRNA; Glucose results in increased expression of AQP3 protein		 CTD PMID:12234316 NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720 		JBrowse link
G Aqp4 aquaporin 4 multiple interactions
increases expression		 EXP benazepril inhibits the reaction [Glucose results in increased expression of AQP4 mRNA]; valsartan inhibits the reaction [Glucose results in increased expression of AQP4 mRNA] CTD PMID:11510275 NCBI chr18:6,507,903...6,524,558
Ensembl chr18:6,507,903...6,524,856 		JBrowse link
G Aqp5 aquaporin 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of AQP5 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of AQP5 mRNA CTD PMID:37567420 NCBI chr 7:130,722,675...130,726,207
Ensembl chr 7:130,721,748...130,726,209 		JBrowse link
G Aqp8 aquaporin 8 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of AQP8 mRNA CTD PMID:37567420 NCBI chr 1:177,993,313...177,999,158
Ensembl chr 1:177,993,305...177,999,158 		JBrowse link
G Ar androgen receptor multiple interactions EXP
ISO		 [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of AR mRNA; tetrahydropalmatine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of AR mRNA]
[2,4-Dichlorophenoxyacetic Acid co-treated with Glyphosate co-treated with lard co-treated with Cholesterol co-treated with Glucose co-treated with Sucrose co-treated with Fructose] results in decreased expression of AR protein		 CTD PMID:37606869 PMID:37615203 NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925 		JBrowse link
G Areg amphiregulin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of AREG mRNA CTD PMID:37567420 NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535 		JBrowse link
G Arg2 arginase 2 increases expression ISO Glucose results in increased expression of ARG2 mRNA CTD PMID:17178593 NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378 		JBrowse link
G Arhgap6 Rho GTPase activating protein 6 increases expression ISO Glucose results in increased expression of ARHGAP6 mRNA CTD PMID:31525975 NCBI chr  X:24,953,464...25,490,003
Ensembl chr  X:24,953,464...25,488,663 		JBrowse link
G Arhgdib Rho GDP dissociation inhibitor beta decreases expression
multiple interactions		 ISO Glucose results in decreased expression of ARHGDIB mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ARHGDIB mRNA]		 CTD PMID:33448797 NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658 		JBrowse link
G Arl4d ARF like GTPase 4D multiple interactions EXP [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ARL4D mRNA; ARL4D protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr10:86,592,054...86,602,843
Ensembl chr10:86,595,661...86,602,836 		JBrowse link
G Arl5b ARF like GTPase 5B increases expression ISO Glucose results in increased expression of ARL5B mRNA CTD PMID:17178593 NCBI chr17:77,955,864...77,979,895
Ensembl chr17:77,955,818...77,979,854 		JBrowse link
G Arl5c ARF like GTPase 5C multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of ARL5C mRNA CTD PMID:37567420 NCBI chr10:82,985,213...82,993,425
Ensembl chr10:82,985,216...82,992,002 		JBrowse link
G Armcx6 armadillo repeat containing, X-linked 6 multiple interactions
increases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of ARMCX6 mRNA] CTD PMID:33448797 NCBI chr  X:97,929,032...97,932,031
Ensembl chr  X:97,929,041...97,931,977 		JBrowse link
G Arnt aryl hydrocarbon receptor nuclear translocator multiple interactions
increases activity		 ISO [Glucose co-treated with Deferoxamine] results in increased expression of ARNT mRNA; Glucose promotes the reaction [[ARNT protein binds to G6PC1 promoter] which results in increased expression of G6PC1 mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of ARNT mRNA]
[Glucose co-treated with Oxygen deficiency] inhibits the reaction [ARNT protein binds to HIF1A protein]
Glucose results in increased activity of ARNT protein		 CTD PMID:15767253 PMID:18227068 PMID:33962019 NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580 		JBrowse link
G Arsj arylsulfatase family, member J multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of ARSJ mRNA CTD PMID:37567420 NCBI chr 2:214,774,631...214,854,614
Ensembl chr 2:214,774,654...214,854,612 		JBrowse link
G Ascl1 achaete-scute family bHLH transcription factor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ASCL1 mRNA CTD PMID:37567420 NCBI chr 7:21,903,136...21,906,003
Ensembl chr 7:21,903,126...21,905,993 		JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) affects expression ISO Glucose affects the expression of ASNS mRNA CTD PMID:17409444 NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423 		JBrowse link
G Aspg asparaginase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of ASPG mRNA CTD PMID:37567420 NCBI chr 6:131,176,727...131,196,268
Ensembl chr 6:131,176,874...131,196,268 		JBrowse link
G Aspn asporin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of ASPN mRNA CTD PMID:37567420 NCBI chr17:15,079,910...15,104,369
Ensembl chr17:15,080,639...15,104,041 		JBrowse link
G Atad1 ATPase family, AAA domain containing 1 multiple interactions EXP ATAD1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:230,544,227...230,610,524
Ensembl chr 1:230,544,047...230,596,548 		JBrowse link
G Atf3 activating transcription factor 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of ATF3 mRNA CTD PMID:37567420 NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631 		JBrowse link
G Atf4 activating transcription factor 4 increases expression
increases response to substance
multiple interactions		 ISO
EXP		 Glucose deficiency results in increased expression of ATF4 mRNA
ATF4 protein results in increased susceptibility to Glucose
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF4 protein]
Glucose deficiency results in increased expression of ATF4 protein
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF4 protein]; [Galactose co-treated with Glucose deficiency] promotes the reaction [Leflunomide results in increased expression of ATF4 protein]; salubrinal inhibits the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF4 protein]]		 CTD PMID:27226639 PMID:27278863 PMID:29427785 PMID:31022492 PMID:34801538 NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446 		JBrowse link
G Atf6 activating transcription factor 6 increases expression
multiple interactions		 ISO
EXP		 Glucose deficiency results in increased expression of ATF6 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ATF6 protein]; Glucose results in increased expression of and affects the localization of ATF6 protein; Metformin inhibits the reaction [Glucose results in increased expression of and affects the localization of ATF6 protein]
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of ATF6 protein]; ATF6 protein modified form promotes the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased expression of HSPA5 protein]]		 CTD PMID:31022492 PMID:34801538 NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177 		JBrowse link
G Atg10 autophagy related 10 increases expression
multiple interactions		 ISO Glucose results in increased expression of ATG10 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of ATG10 mRNA]		 CTD PMID:33448797 NCBI chr 2:22,109,304...22,398,313
Ensembl chr 2:22,108,426...22,398,233 		JBrowse link
G Atg3 autophagy related 3 increases expression EXP Glucose results in increased expression of ATG3 mRNA CTD PMID:38444079 NCBI chr11:55,624,914...55,653,249
Ensembl chr11:55,624,917...55,653,224 		JBrowse link
G Atg5 autophagy related 5 multiple interactions
increases expression
decreases expression		 EXP 3-methyladenine inhibits the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]]; [Glucose co-treated with Lycopene] results in increased expression of ATG5 mRNA; N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]; Sirolimus promotes the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]]; ULK1 protein affects the reaction [Glucose results in decreased expression of ATG5 protein]; ULK1 protein affects the reaction [N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide inhibits the reaction [Glucose results in decreased expression of ATG5 protein]]
Glucose results in increased expression of ATG5 mRNA		 CTD PMID:29128638 PMID:38444079 NCBI chr20:47,798,217...47,889,216
Ensembl chr20:47,798,290...47,889,209 		JBrowse link
G Atg7 autophagy related 7 multiple interactions
decreases expression		 EXP Inositol inhibits the reaction [Glucose results in decreased expression of ATG7 protein] CTD PMID:35243728 NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593 		JBrowse link
G Atl1 atlastin GTPase 1 multiple interactions EXP ATL1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 6:88,377,168...88,475,242
Ensembl chr 6:88,377,239...88,475,204 		JBrowse link
G Atox1 antioxidant 1 copper chaperone increases expression ISO Glucose results in increased expression of ATOX1 mRNA CTD PMID:32942007 NCBI chr10:39,564,855...39,579,892
Ensembl chr10:39,564,857...39,579,950 		JBrowse link
G Atp1a1 ATPase Na+/K+ transporting subunit alpha 1 multiple interactions ISO
EXP		 Glucose results in decreased expression of and results in decreased activity of ATP1A1 protein; INS protein inhibits the reaction [Glucose results in decreased expression of ATP1A1 protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and affects the localization of ATP1A1 protein; Antigen-Antibody Complex inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of and affects the localization of ATP1A1 protein]		 CTD PMID:22162761 PMID:29702141 NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837 		JBrowse link
G Atp2a1 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 decreases expression
multiple interactions		 ISO Glucose results in decreased expression of ATP2A1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of ATP2A1 mRNA]		 CTD PMID:31525975 PMID:33448797 NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838 		JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha multiple interactions EXP [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of ATP5F1A protein CTD PMID:25997894 NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794 		JBrowse link
G Atp5f1d ATP synthase F1 subunit delta multiple interactions EXP 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein]]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein]; Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of ATP5F1D protein] CTD PMID:25305180 NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929 		JBrowse link
G Atp6ap2 ATPase H+ transporting accessory protein 2 increases expression
multiple interactions		 EXP Glucose results in increased expression of ATP6AP2 mRNA; Glucose results in increased expression of ATP6AP2 protein
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 mRNA]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Glucose results in increased expression of ATP6AP2 protein]		 CTD PMID:19861503 NCBI chr  X:10,183,983...10,210,948
Ensembl chr  X:10,183,068...10,210,918 		JBrowse link
G Aurka aurora kinase A increases expression ISO Glucose results in increased expression of AURKA mRNA CTD PMID:17178593 NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390 		JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding affects secretion ISO Glucose deficiency affects the secretion of AZGP1 protein CTD PMID:24802182 NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091 		JBrowse link
G B2m beta-2 microglobulin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of B2M mRNA CTD PMID:37567420 NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766 		JBrowse link
G B3gat3 beta-1,3-glucuronyltransferase 3 increases expression
multiple interactions		 EXP Glucose results in increased expression of B3GAT3 mRNA
[XDH protein co-treated with Hypoxanthine] inhibits the reaction [Glucose results in increased expression of B3GAT3 mRNA]; IL1B protein inhibits the reaction [Glucose results in increased expression of B3GAT3 mRNA]		 CTD PMID:11801247 NCBI chr 1:205,817,374...205,823,928
Ensembl chr 1:205,817,378...205,837,807 		JBrowse link
G B3gnt6 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of B3GNT6 mRNA CTD PMID:37567420 NCBI chr 1:152,484,572...152,496,226
Ensembl chr 1:152,486,343...152,492,150 		JBrowse link
G B4galnt4 beta-1,4-N-acetyl-galactosaminyl transferase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of B4GALNT4 mRNA CTD PMID:37567420 NCBI chr 1:196,171,394...196,182,294
Ensembl chr 1:196,171,394...196,182,294 		JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions
increases expression		 ISO
EXP		 [resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [Glucose results in decreased phosphorylation of and results in decreased activity of BAD protein]; Glucose results in decreased phosphorylation of and results in decreased activity of BAD protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAD protein
Glucose results in increased expression of BAD mRNA		 CTD PMID:17293559 PMID:20370652 PMID:38444079 NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823 		JBrowse link
G Bak1 BCL2-antagonist/killer 1 multiple interactions
increases expression		 EXP
ISO		 [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Carvedilol] which results in decreased expression of BAK1 mRNA
Glucose results in increased expression of BAK1 mRNA
[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAK1 mRNA]		 CTD PMID:29122578 PMID:33962019 PMID:38444079 NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264 		JBrowse link
G Bambi BMP and activin membrane-bound inhibitor multiple interactions
increases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of BAMBI mRNA] CTD PMID:33448797 NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060 		JBrowse link
G Barx2 BARX homeobox 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of BARX2 mRNA CTD PMID:37567420 NCBI chr 8:30,251,132...30,319,105
Ensembl chr 8:30,251,132...30,319,013 		JBrowse link
G Batf2 basic leucine zipper ATF-like transcription factor 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of BATF2 mRNA CTD PMID:37567420 NCBI chr 1:203,467,291...203,479,428
Ensembl chr 1:203,468,097...203,475,889 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
multiple interactions
affects expression		 ISO
EXP		 Glucose results in increased expression of BAX mRNA; Glucose results in increased expression of BAX protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in increased expression of BAX protein]]; [Carnosine co-treated with asiatic acid] inhibits the reaction [Glucose results in increased expression of BAX mRNA]; [Glucose co-treated with Deferoxamine] results in increased expression of BAX mRNA; [Glucose co-treated with Deferoxamine] results in increased expression of BAX protein; asiatic acid inhibits the reaction [Glucose results in increased expression of BAX mRNA]; Carnosine inhibits the reaction [Glucose results in increased expression of BAX mRNA]; diallyl trisulfide inhibits the reaction [Glucose results in increased expression of BAX protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAX mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BAX protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of BAX protein]]; MIR142 inhibits the reaction [Glucose results in increased expression of BAX protein]; MitoTEMPO inhibits the reaction [Glucose results in increased expression of BAX protein]; NDRG2 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; polyethylene glycol loxenatide inhibits the reaction [Glucose results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]; salvianolic acid inhibits the reaction [Glucose results in increased expression of BAX protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of BAX protein]]; spiraeoside inhibits the reaction [Glucose results in increased expression of BAX protein]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of BAX protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one promotes the reaction [[Glucose co-treated with Bupivacaine] results in increased expression of BAX protein]; [Glucose co-treated with Bupivacaine] results in increased expression of BAX protein; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein modified form; CEBPB protein inhibits the reaction [Glucose results in increased expression of BAX protein]; gastrodin inhibits the reaction [Glucose results in increased expression of BAX protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX mRNA]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of BAX protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]; Valsartan inhibits the reaction [Glucose results in increased expression of BAX protein]
3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in increased expression of BAX protein]; [Dithionite co-treated with Glucose deficiency] results in increased expression of BAX protein; [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in increased expression of BAX protein]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased expression of BAX protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]]; cinnamic acid inhibits the reaction [Glucose results in increased expression of BAX protein]; Diosgenin inhibits the reaction [Glucose results in increased expression of BAX protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]]; gastrodin inhibits the reaction [Glucose results in increased expression of BAX protein]; Metformin inhibits the reaction [Glucose results in increased expression of BAX protein]; morroniside inhibits the reaction [Glucose results in increased expression of BAX protein]; naringenin inhibits the reaction [Glucose results in increased expression of BAX mRNA]; naringenin inhibits the reaction [Glucose results in increased expression of BAX protein]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased expression of BAX protein]; Quercetin affects the reaction [Glucose affects the expression of BAX protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in increased expression of BAX protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of BAX protein]; Scopoletin inhibits the reaction [Glucose results in increased expression of BAX protein]; sesamin affects the reaction [Glucose affects the expression of BAX protein]; STIM1 protein affects the reaction [Glucose results in increased expression of BAX protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BAX protein]		 CTD PMID:21803128 PMID:22524206 PMID:23192364 PMID:23451161 PMID:24218232 More... NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Bbc3 Bcl-2 binding component 3 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of BBC3 mRNA; [Palmitic Acid co-treated with Glucose] results in increased expression of BBC3 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BBC3 mRNA]; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of BBC3 mRNA]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein modified form; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BBC3 protein]		 CTD PMID:24451382 PMID:28675767 PMID:33962019 NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509 		JBrowse link
G Bche butyrylcholinesterase multiple interactions
increases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of BCHE mRNA] CTD PMID:33448797 NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148 		JBrowse link
G Bcl11a BCL11 transcription factor A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of BCL11A mRNA CTD PMID:37567420 NCBI chr14:98,029,018...98,124,181
Ensembl chr14:98,030,461...98,124,180 		JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression
affects expression
multiple interactions		 ISO
EXP		 Glucose results in decreased expression of BCL2 mRNA; Glucose results in decreased expression of BCL2 protein
Glucose affects the expression of BCL2 mRNA; Glucose affects the expression of BCL2 protein
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; [Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; [Glucose co-treated with Lycopene] results in increased expression of BCL2 mRNA; [Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of BCL2 protein]; [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Glucose deficiency] affects the expression of BCL2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; Chlorogenic Acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; cinnamic acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Diosgenin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; gastrodin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Metformin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; morroniside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; naringenin inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]; naringenin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]; Quercetin affects the reaction [Glucose affects the expression of BCL2 protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; Resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Scopoletin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; sesamin affects the reaction [Glucose affects the expression of BCL2 protein]; STIM1 protein affects the reaction [Glucose results in decreased expression of BCL2 protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; [Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 mRNA; [Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 protein; [Resveratrol co-treated with Glucose] results in increased expression of BCL2 protein; asiatic acid inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]; asiatic acid promotes the reaction [Carnosine inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]]; Berberine inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Carnosine inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]; Carnosine promotes the reaction [asiatic acid inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]]; Catechin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; diallyl trisulfide inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; epigallocatechin gallate inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; Gliclazide inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]; Glucose results in increased degradation of and results in decreased expression of BCL2 protein; Luteolin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in decreased expression of BCL2 protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in decreased expression of BCL2 protein]]; MIR142 inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; MitoTEMPO inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; NS 1619 inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]; polyethylene glycol loxenatide inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Quercetin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; Rutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]; salvianolic acid inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]; spiraeoside inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; Tamoxifen inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in decreased expression of BCL2 protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one promotes the reaction [[Glucose co-treated with Bupivacaine] results in decreased expression of BCL2 protein]; [Glucose co-treated with Bupivacaine] results in decreased expression of BCL2 protein; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA; [Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]]; gastrodin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 mRNA]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]; MIR210 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]		 CTD PMID:18088078 PMID:19557821 PMID:21413024 PMID:21803128 PMID:21818840 More... NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743 		JBrowse link
G Bcl2l1 Bcl2-like 1 multiple interactions EXP BCL2L1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
Ensembl chr 1:141,253,523...141,303,479 		JBrowse link
G Bcl2l11 Bcl2-like 11 multiple interactions
increases expression		 EXP 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein]]; resveratrol inhibits the reaction [Glucose results in increased expression of BCL2L11 protein] CTD PMID:25471227 NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068 		JBrowse link
G Bcl2l15 Bcl2-like 15 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of BCL2L15 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BCL2L15 mRNA] CTD PMID:33962019 NCBI chr 2:191,338,959...191,344,078
Ensembl chr 2:191,338,959...191,344,078 		JBrowse link
G Bco1 beta-carotene oxygenase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of BCO1 mRNA CTD PMID:37567420 NCBI chr19:45,149,250...45,186,102
Ensembl chr19:45,149,265...45,186,101 		JBrowse link
G Bdkrb1 bradykinin receptor B1 increases expression
multiple interactions		 EXP Glucose results in increased expression of BDKRB1 protein
argan oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein]; Corn Oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein]		 CTD PMID:29165388 NCBI chr 6:124,510,827...124,514,475
Ensembl chr 6:124,510,870...124,513,747 		JBrowse link
G Becn1 beclin 1 multiple interactions
increases expression
decreases expression		 EXP
ISO		 [Glucose co-treated with Lycopene] results in increased expression of BECN1 mRNA; [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in decreased expression of BECN1 protein]; [Resveratrol co-treated with Glucose] results in increased expression of BECN1 protein; Inositol inhibits the reaction [Glucose results in decreased expression of BECN1 protein]
Glucose results in increased expression of BECN1 mRNA
Glucose results in increased expression of BECN1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]]; Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]]; HU 308 inhibits the reaction [Glucose results in decreased expression of BECN1 protein]		 CTD PMID:25997894 PMID:28713934 PMID:30459625 PMID:33450223 PMID:35243728 More... NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742 		JBrowse link
G Begain brain-enriched guanylate kinase-associated multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of BEGAIN mRNA CTD PMID:37567420 NCBI chr 6:127,943,651...127,979,876
Ensembl chr 6:127,943,651...127,979,841 		JBrowse link
G Bglap bone gamma-carboxyglutamate protein multiple interactions
decreases expression		 ISO
EXP		 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP protein]]; Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]]; Sirolimus inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]]
morroniside inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of BGLAP protein]
Glucose results in decreased expression of BGLAP mRNA; Glucose results in decreased expression of BGLAP protein		 CTD PMID:32643284 PMID:33450223 NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495 		JBrowse link
G Bhmt betaine-homocysteine S-methyltransferase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of BHMT mRNA CTD PMID:37567420 NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742 		JBrowse link
G Bid BH3 interacting domain death agonist multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of BID mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BID mRNA] CTD PMID:33962019 NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720 		JBrowse link
G Bmp2 bone morphogenetic protein 2 decreases expression
multiple interactions		 ISO
EXP		 Glucose results in decreased expression of BMP2 mRNA
cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of BMP2 mRNA]; tin mesoporphyrin promotes the reaction [Glucose results in decreased expression of BMP2 mRNA]
morroniside inhibits the reaction [Glucose results in decreased expression of BMP2 mRNA]		 CTD PMID:19924377 PMID:32643284 NCBI chr 3:120,812,660...120,822,579
Ensembl chr 3:120,812,882...120,821,397 		JBrowse link
G Bmp8a bone morphogenetic protein 8a multiple interactions
decreases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of BMP8B mRNA] CTD PMID:31525975 PMID:33448797 NCBI chr 5:135,589,839...135,617,785
Ensembl chr 5:135,591,716...135,617,785 		JBrowse link
G Bmper BMP-binding endothelial regulator multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of BMPER mRNA CTD PMID:37567420 NCBI chr 8:21,732,225...21,977,261
Ensembl chr 8:21,732,225...21,977,256 		JBrowse link
G Bnip3 BCL2 interacting protein 3 multiple interactions ISO [Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3 mRNA] CTD PMID:33962019 NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359 		JBrowse link
G Bnip3l BCL2 interacting protein 3 like multiple interactions
decreases expression		 ISO
EXP		 [Glucose co-treated with Deferoxamine] results in increased expression of BNIP3L mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of BNIP3L mRNA]
Glucose results in decreased expression of BNIP3L protein
Inositol inhibits the reaction [Glucose results in decreased expression of BNIP3L protein]		 CTD PMID:33962019 PMID:35243728 NCBI chr15:41,174,594...41,197,730
Ensembl chr15:41,174,594...41,197,803 		JBrowse link
G Bst2 bone marrow stromal cell antigen 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of BST2 mRNA CTD PMID:37567420 NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979 		JBrowse link
G Btbd17 BTB domain containing 17 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of BTBD17 mRNA CTD PMID:37567420 NCBI chr10:99,826,132...99,832,624
Ensembl chr10:99,826,132...99,832,624 		JBrowse link
G C1qtnf3 C1q and TNF related 3 decreases expression ISO Glucose results in decreased expression of C1QTNF3 mRNA CTD PMID:31525975 NCBI chr 2:59,917,099...59,939,519
Ensembl chr 2:59,917,188...59,939,433 		JBrowse link
G C1r complement C1r decreases secretion ISO Glucose deficiency results in decreased secretion of C1R protein CTD PMID:24802182 NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484 		JBrowse link
G C1s complement C1s affects secretion ISO Glucose deficiency affects the secretion of C1S protein CTD PMID:24802182 NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303 		JBrowse link
G C3 complement C3 increases expression
multiple interactions		 ISO Glucose results in increased expression of C3 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of C3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of C3 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of C3 mRNA		 CTD PMID:17178593 PMID:23199288 PMID:37567420 NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429 		JBrowse link
G C4b complement C4B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of C4B mRNA CTD PMID:37567420 NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681 		JBrowse link
G C5 complement C5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of HC mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of HC mRNA CTD PMID:37567420 NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994 		JBrowse link
G C5ar1 complement C5a receptor 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of C5AR1 mRNA CTD PMID:37567420 NCBI chr 1:76,948,622...76,959,826 JBrowse link
G Cabp4 calcium binding protein 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CABP4 mRNA CTD PMID:37567420 NCBI chr 1:201,428,671...201,442,950
Ensembl chr 1:201,428,672...201,433,172 		JBrowse link
G Cacna1s calcium voltage-gated channel subunit alpha1 S multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CACNA1S mRNA CTD PMID:37567420 NCBI chr13:47,493,949...47,564,194
Ensembl chr13:47,493,949...47,564,318 		JBrowse link
G Calca calcitonin-related polypeptide alpha increases expression
multiple interactions		 ISO Glucose results in increased expression of CALCA mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CALCA mRNA		 CTD PMID:31655124 PMID:37567420 NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105 		JBrowse link
G Calm2 calmodulin 2 multiple interactions EXP CALM2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 6:7,091,624...7,104,284
Ensembl chr 6:7,091,567...7,104,287
Ensembl chr15:7,091,567...7,104,287 		JBrowse link
G Calr calreticulin decreases expression ISO Glucose results in decreased expression of CALR mRNA CTD PMID:17178593 NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414 		JBrowse link
G Calu calumenin decreases secretion ISO Glucose deficiency results in decreased secretion of CALU protein CTD PMID:24802182 NCBI chr 4:57,949,086...57,976,589
Ensembl chr 4:57,948,997...57,976,593 		JBrowse link
G Caly calcyon neuron-specific vesicular protein multiple interactions EXP CALY protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:194,862,671...194,873,861
Ensembl chr 1:194,862,672...194,873,551 		JBrowse link
G Canx calnexin decreases expression
multiple interactions
increases expression		 ISO
EXP		 Glucose results in decreased expression of CANX mRNA
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of CANX protein]		 CTD PMID:17178593 PMID:34801538 NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821 		JBrowse link
G Capn1 calpain 1 multiple interactions
increases expression		 EXP
ISO		 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside inhibits the reaction [[Oxygen co-treated with Glucose deficiency] results in increased expression of CAPN1 protein]; [Oxygen co-treated with Glucose deficiency] results in increased expression of CAPN1 protein
Glucose results in increased expression of CAPN1 protein
Furans analog inhibits the reaction [Glucose results in increased expression of CAPN1 protein]		 CTD PMID:24726522 PMID:28911973 NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177 		JBrowse link
G Car3 carbonic anhydrase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CAR3 mRNA CTD PMID:37567420 NCBI chr 2:86,770,418...86,780,011
Ensembl chr 2:86,770,420...86,784,280 		JBrowse link
G Casp1 caspase 1 multiple interactions
increases activity
increases expression
increases cleavage		 ISO
EXP		 Acetylcysteine inhibits the reaction [Glucose results in increased cleavage of CASP1 protein]; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP1 protein]; Glucose results in increased cleavage of and results in increased activity of CASP1 protein; Glucose results in increased expression of and results in increased cleavage of CASP1 protein
Glucose results in increased activity of CASP1 mRNA; Glucose results in increased activity of CASP1 protein
Glucose results in increased expression of CASP1 mRNA; Glucose results in increased expression of CASP1 protein
[Glucose co-treated with TGFB1 protein] results in increased cleavage of CASP1 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein; Allopurinol inhibits the reaction [Glucose results in increased expression of CASP1 protein]; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased cleavage of CASP1 protein]; bellidifolin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein]; Glucose results in increased expression of and results in increased cleavage of CASP1 protein; HAGLR protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of CASP1 protein]; HAGLR protein promotes the reaction [Glucose results in increased expression of and results in increased cleavage of CASP1 protein]; L 709049 analog inhibits the reaction [Glucose results in increased expression of CASP1 protein]; Lipopolysaccharides inhibits the reaction [swietenine inhibits the reaction [Glucose results in increased expression of CASP1 protein]]; Lipopolysaccharides promotes the reaction [Glucose results in increased expression of CASP1 protein]; loganin inhibits the reaction [Glucose results in increased expression of CASP1 mRNA]; loganin inhibits the reaction [Glucose results in increased expression of CASP1 protein]; MIR200C mRNA affects the reaction [Glucose results in increased cleavage of CASP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide inhibits the reaction [Glucose results in increased expression of CASP1 protein]; N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide promotes the reaction [swietenine inhibits the reaction [Glucose results in increased expression of CASP1 protein]]; PTEN protein affects the reaction [HAGLR protein affects the reaction [Glucose results in increased expression of and results in increased cleavage of CASP1 protein]]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP1 protein]; SLC30A7 protein affects the reaction [MIR200C mRNA affects the reaction [Glucose results in increased cleavage of CASP1 protein]]; swietenine inhibits the reaction [Glucose results in increased expression of CASP1 protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of CASP1 protein]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein modified form; Allopurinol inhibits the reaction [Glucose results in increased expression of CASP1 protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP1 protein modified form]; L 709049 analog inhibits the reaction [Glucose results in increased expression of CASP1 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP1 protein]; rhodioloside inhibits the reaction [Glucose results in increased expression of CASP1 protein]; Suramin inhibits the reaction [Glucose results in increased activity of CASP1 protein]; TXNIP mRNA promotes the reaction [Glucose results in increased expression of CASP1 protein]		 CTD PMID:20370652 PMID:21832250 PMID:23647015 PMID:27783111 PMID:29031534 More... NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383 		JBrowse link
G Casp12 caspase 12 multiple interactions
increases expression
increases cleavage		 ISO
EXP		 TRPM7 protein affects the reaction [Glucose results in increased cleavage of CASP12 protein]; waixenicin A inhibits the reaction [Glucose results in increased cleavage of CASP12 protein]
Glucose results in increased expression of CASP12 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of CASP12 protein]		 CTD PMID:30076216 PMID:34801538 NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037 		JBrowse link
G Casp3 caspase 3 multiple interactions
increases activity
increases expression
increases cleavage
decreases expression		 ISO
EXP		 [Carnosine co-treated with asiatic acid] inhibits the reaction [Glucose results in increased activity of CASP3 protein]; [Glucose co-treated with Deferoxamine] results in increased expression of CASP3 mRNA; [Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein; [Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein modified form; [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP3 protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP3 protein; [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP3 protein; [Palmitic Acid co-treated with Glucose] results in increased cleavage of CASP3 protein; asiatic acid inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Captopril inhibits the reaction [Glucose results in increased expression of CASP3 mRNA]; Carnosine inhibits the reaction [Glucose results in increased activity of CASP3 protein]; diallyl trisulfide inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Fluorometholone inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Gliclazide inhibits the reaction [Glucose results in increased expression of CASP3 protein]; huai qi huang inhibits the reaction [Glucose results in increased expression of CASP3 mRNA]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of CASP3 protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP3 mRNA]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein modified form]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP3 protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased cleavage of CASP3 protein]]; MIR142 inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; MitoTEMPO inhibits the reaction [Glucose results in increased activity of CASP3 protein]; polyethylene glycol loxenatide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Rosiglitazone inhibits the reaction [Glucose results in increased activity of CASP3 protein]; rutecarpine inhibits the reaction [Glucose results in increased activity of CASP3 protein]; salvianolic acid inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; SIRT1 protein inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased cleavage of CASP3 protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased cleavage of CASP3 protein]
Glucose results in increased expression of CASP3 mRNA; Glucose results in increased expression of CASP3 protein
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]; [Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein; [Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA; [Glucose deficiency co-treated with Simvastatin] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP3 protein]; gastrodin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Glucose deficiency inhibits the reaction [Arsenic Trioxide results in increased expression of CASP3 protein modified form]; Glucose results in increased cleavage of and results in increased activity of CASP3 protein; HIF1A protein affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; HIF1A protein affects the reaction [MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; INO 1001 inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]]; Isoflurane inhibits the reaction [2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide promotes the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; Isoflurane inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of CASP3 mRNA]; MIR144 mRNA promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; MIR186 mRNA affects the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; MIR186 mRNA inhibits the reaction [[Glucose deficiency co-treated with Oxygen deficiency] results in increased cleavage of CASP3 protein]; MIR322 affects the reaction [Glucose results in increased cleavage of CASP3 protein]; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein]; SIRT7 protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; TRAF3 affects the reaction [Glucose results in increased cleavage of CASP3 protein]; TRPM7 protein affects the reaction [Glucose results in increased cleavage of CASP3 protein]; U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein]; VDAC1 protein inhibits the reaction [Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; VDAC1 protein promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; waixenicin A inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; zinc protoporphyrin inhibits the reaction [[Glucose deficiency co-treated with Simvastatin] results in increased cleavage of CASP3 protein]
Glucose results in increased activity of CASP3; Glucose results in increased activity of CASP3 protein
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [2-chloro-N(6)cyclopentyladenosine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [LY 379268 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; 2-chloro-N(6)cyclopentyladenosine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; [Dithionite co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; [Glucose co-treated with Lycopene] results in increased expression of CASP3 mRNA; [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]; [morroniside co-treated with Diosgenin] inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased activity of CASP3 protein; [Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] affects the expression of and affects the activity of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased cleavage of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein; [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP3]; Antigen-Antibody Complex inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Chlorogenic Acid inhibits the reaction [Glucose results in increased activity of CASP3 protein]; cinnamic acid inhibits the reaction [Glucose results in increased activity of CASP3 protein]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]; diallyl trisulfide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Diosgenin inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]; gastrodin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Glucose results in increased expression of and results in increased activity of CASP3 protein; Glucose results in increased expression of and results in increased cleavage of CASP3 protein; GSK3B protein inhibits the reaction [MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; HMOX1 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; HMOX1 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; IGF2R protein modified form inhibits the reaction [Glucose results in increased expression of CASP3 protein modified form]; IGF2R protein modified form inhibits the reaction [Glucose results in increased expression of CASP3 protein]; KEAP1 protein inhibits the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; LY 379268 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Metformin inhibits the reaction [Glucose results in increased activity of CASP3 protein]; Metformin inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; MIR135A mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; morroniside inhibits the reaction [Glucose results in increased expression of and results in increased activity of CASP3 protein]; naringenin inhibits the reaction [Glucose results in increased activity of CASP3 protein]; naringenin inhibits the reaction [Glucose results in increased expression of and results in increased cleavage of CASP3 protein]; naringenin inhibits the reaction [Glucose results in increased expression of CASP3 mRNA]; NFE2L2 mutant form inhibits the reaction [diallyl trisulfide inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; NFE2L2 protein mutant form affects the reaction [plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; NFE2L2 protein promotes the reaction [diallyl trisulfide inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; NFE2L2 protein promotes the reaction [diosmetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein modified form]]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased activity of CASP3 protein]; notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein]; plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; Quercetin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CASP3 protein]; Quercetin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP3 mRNA]; Quercetin inhibits the reaction [Glucose results in increased expression of CASP3 protein modified form]; Scopoletin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; sesamin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; Simvastatin inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]; STAT3 protein affects the reaction [Propofol inhibits the reaction [Glucose results in increased cleavage of CASP3 protein]]; STIM1 protein affects the reaction [Glucose results in increased cleavage of CASP3 protein]; trigonelline inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; U 0126 inhibits the reaction [2-chloro-N(6)cyclopentyladenosine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; U 0126 inhibits the reaction [LY 379268 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; WDR35 protein affects the reaction [Glucose results in increased activity of CASP3 protein]; Y 27632 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in increased cleavage of CASP3 protein]
Glucose results in increased expression of CASP3 mRNA; Glucose results in increased expression of CASP3 protein; Glucose results in increased expression of CASP3 protein modified form
Glucose results in decreased expression of CASP3 mRNA		 CTD PMID:15322300 PMID:16135072 PMID:17065336 PMID:17293559 PMID:17309078 More... NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp8 caspase 8 increases activity
increases expression
multiple interactions		 ISO
EXP		 Glucose results in increased activity of CASP8 protein
Glucose results in increased expression of CASP8 mRNA
[Glucose co-treated with Deferoxamine] results in increased expression of CASP8 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CASP8 mRNA]
[Glucose co-treated with Lycopene] results in increased expression of CASP8 mRNA; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP8]		 CTD PMID:18791325 PMID:18973755 PMID:33962019 PMID:38444079 NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542 		JBrowse link
G Casp9 caspase 9 multiple interactions
increases cleavage
increases expression
increases activity		 ISO
EXP		 [Glucose deficiency co-treated with Acetylcysteine] results in increased activity of CASP9 protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP9 protein; [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP9 protein; salvianolic acid inhibits the reaction [Glucose results in increased cleavage of CASP9 protein]
Glucose results in increased expression of CASP9 mRNA; Glucose results in increased expression of CASP9 protein
[Glucose co-treated with IGF2R protein modified form] results in increased expression of CASP9 protein; [Glucose co-treated with Lycopene] results in increased expression of CASP9 mRNA; [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased activity of CASP9]; Glucose results in increased expression of and results in increased cleavage of CASP9 protein; naringenin inhibits the reaction [Glucose results in increased expression of and results in increased cleavage of CASP9 protein]; naringenin inhibits the reaction [Glucose results in increased expression of CASP9 mRNA]; Scopoletin inhibits the reaction [Glucose results in increased expression of CASP9 protein]		 CTD PMID:17309078 PMID:18791325 PMID:23192364 PMID:25997894 PMID:30431688 More... NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626 		JBrowse link
G Casz1 castor zinc finger 1 increases expression
multiple interactions		 ISO Glucose results in increased expression of CASZ1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of CASZ1 mRNA]		 CTD PMID:33448797 NCBI chr 5:159,243,965...159,393,935
Ensembl chr 5:159,243,995...159,393,400 		JBrowse link
G Cat catalase multiple interactions
decreases expression
increases expression
decreases activity
increases activity		 ISO
EXP		 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [spiraeoside inhibits the reaction [Glucose results in increased activity of CAT protein]]; [Glucose deficiency co-treated with CAT] affects the localization of ENDOG protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP3 protein; [Glucose deficiency co-treated with CAT] results in increased activity of CASP9 protein; [Glucose deficiency co-treated with CAT] results in increased cleavage of PARP1 protein; CAT inhibits the reaction [Glucose deficiency affects the folding of SOD2 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK1 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK14 protein]; CAT inhibits the reaction [Glucose deficiency results in increased activity of MAPK3 protein]; CAT inhibits the reaction [Glucose deficiency results in increased degradation of SOD1 protein]; CAT protein inhibits the reaction [Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]]; cyclopamine inhibits the reaction [SHH protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]]; Furans analog inhibits the reaction [Glucose results in decreased activity of CAT protein]; SHH protein inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of CAT protein]; solanesol inhibits the reaction [Glucose results in decreased activity of CAT protein]; spiraeoside inhibits the reaction [Glucose results in increased activity of CAT protein]
Glucose results in decreased expression of CAT mRNA
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]]; [Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in decreased activity of CAT protein; CAT protein inhibits the reaction [Glucose results in increased expression of AGT mRNA]; CAT protein inhibits the reaction [Glucose results in increased expression of AGT protein]; CAT protein inhibits the reaction [Glucose results in increased expression of GNA11 protein]; CAT protein inhibits the reaction [Glucose results in increased expression of GNAQ protein]; CAT protein inhibits the reaction [Glucose results in increased expression of PLCB1 protein]; CAT protein inhibits the reaction [Glucose results in increased expression of PLCB2 protein]; gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]; naringenin inhibits the reaction [Glucose results in decreased activity of CAT protein]; NFE2L2 protein affects the reaction [gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]]; Resveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency co-treated with Oxygen] results in decreased activity of CAT protein]; Resveratrol inhibits the reaction [Glucose results in decreased activity of CAT protein]
Glucose deficiency results in increased expression of CAT protein; Glucose results in increased expression of CAT protein
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein; cyclopamine inhibits the reaction [polydatin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]]; cyclopamine promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]; gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]; NFE2L2 protein affects the reaction [gastrodin inhibits the reaction [Glucose results in decreased activity of CAT protein]]; polydatin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased activity of CAT protein]		 CTD PMID:12130563 PMID:17309078 PMID:20691780 PMID:21818840 PMID:23192364 More... NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Cav1 caveolin 1 decreases expression
multiple interactions		 ISO Glucose results in decreased expression of CAV1 mRNA; Glucose results in decreased expression of CAV1 protein
EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]; Simvastatin inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]		 CTD PMID:19816600 PMID:31655124 NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705 		JBrowse link
G Cbr3 carbonyl reductase 3 increases expression ISO Glucose results in increased expression of CBR3 mRNA CTD PMID:17178593 NCBI chr11:33,008,615...33,016,877
Ensembl chr11:33,008,615...33,016,875 		JBrowse link
G Cbs cystathionine beta synthase increases expression
decreases expression		 ISO
EXP		 Glucose results in increased expression of CBS mRNA
Glucose deficiency results in decreased expression of CBS mRNA		 CTD PMID:17178593 PMID:35577173 NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764 		JBrowse link
G Ccdc116 coiled-coil domain containing 116 multiple interactions
decreases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of CCDC116 mRNA] CTD PMID:33448797 NCBI chr11:83,842,707...83,850,607
Ensembl chr11:83,845,557...83,850,607 		JBrowse link
G Ccdc169 coiled-coil domain containing 169 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CCDC169 mRNA CTD PMID:37567420 NCBI chr 2:139,321,644...139,351,161
Ensembl chr 2:139,321,670...139,351,161 		JBrowse link
G Ccdc190 coiled-coil domain containing 190 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CCDC190 mRNA CTD PMID:37567420 NCBI chr13:82,147,161...82,154,863
Ensembl chr13:82,147,176...82,154,863 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression
multiple interactions
increases secretion		 ISO
EXP		 Glucose results in increased expression of CCL2 mRNA; Glucose results in increased expression of CCL2 protein
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCL2 protein]; [Glucose co-treated with fatostatin] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL2 mRNA; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; [Resveratrol affects the localization of RELA protein] inhibits the reaction [Glucose results in increased expression of CCL2 protein]; [Valsartan co-treated with Simvastatin] inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]; aspalathin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; aspalathin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Aspirin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Aspirin inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Bezafibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; CCL2 mRNA affects the reaction [Glucose results in increased expression of CCN2 protein]; chromic chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; chromium nicotinic acid complex inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Clofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Clofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; diphenyleneiodonium inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Fenofibrate inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Glucose inhibits the reaction [Fructose results in increased secretion of CCL2 protein]; Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]; HTS 466284 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; isoangustone A inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; manganese chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; nothofagin inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; nothofagin inhibits the reaction [Glucose results in increased expression of CCL2 protein]; picolinic acid inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; psicose inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; psicose inhibits the reaction [Glucose results in increased expression of CCL2 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Quercetin inhibits the reaction [Glucose results in increased expression of MCP1 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased secretion of CCL2 protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of CCL2 protein]; Selenium inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased expression of CCL2 mRNA]; Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of CCL2 mRNA]]
Glucose results in increased expression of CCL2 mRNA; Glucose results in increased expression of CCL2 protein; Glucose results in increased expression of MCP1 mRNA
duanbanhuain A inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; duanbanhuain B inhibits the reaction [Glucose results in increased secretion of CCL2 protein]
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CCL2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CCL2 mRNA; manganese chloride inhibits the reaction [Glucose results in increased secretion of CCL2 protein]; MIR27B mRNA affects the reaction [Glucose results in increased expression of CCL2 protein]; SNHG1 affects the reaction [Glucose results in increased expression of CCL2 mRNA]; SNHG1 affects the reaction [Glucose results in increased expression of CCL2 protein]; SNHG1 affects the reaction [MIR27B mRNA affects the reaction [Glucose results in increased expression of CCL2 protein]]		 CTD PMID:16143069 PMID:16600694 PMID:17178593 PMID:17607302 PMID:17655880 More... NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226 		JBrowse link
G Ccl28 C-C motif chemokine ligand 28 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CCL28 mRNA CTD PMID:37567420 NCBI chr 2:51,601,354...51,625,999
Ensembl chr 2:51,601,331...51,625,997 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 increases expression
multiple interactions
decreases expression		 ISO Glucose results in increased expression of CCL5 mRNA
[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of CCL5 mRNA
Glucose results in decreased expression of CCL5 mRNA		 CTD PMID:17178593 PMID:31655124 PMID:32613381 PMID:32942007 NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377 		JBrowse link
G Ccl7 C-C motif chemokine ligand 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CCL7 mRNA CTD PMID:37567420 NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303 		JBrowse link
G Ccn1 cellular communication network factor 1 increases expression ISO Glucose results in increased expression of CCN1 mRNA CTD PMID:17178593 NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484 		JBrowse link
G Ccn2 cellular communication network factor 2 multiple interactions
increases expression		 ISO
EXP		 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CCN2 protein]; bisindolylmaleimide I inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]; Cadmium inhibits the reaction [Glucose results in increased expression of CCN2 protein]; CCL2 mRNA affects the reaction [Glucose results in increased expression of CCN2 protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of CCN2 protein]; Zinc inhibits the reaction [Glucose results in increased expression of CCN2 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]
Aspirin inhibits the reaction [Glucose results in increased expression of CCN2 mRNA]; CCN2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]; fatostatin inhibits the reaction [Glucose results in increased expression of CCN2 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of CCN2 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of CCN2 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CCN2 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CCN2 protein]]
Glucose results in increased expression of CCN2 mRNA; Glucose results in increased expression of CCN2 protein		 CTD PMID:10026205 PMID:14586741 PMID:19369054 PMID:21124846 PMID:21367880 More... NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734 		JBrowse link
G Ccnb1 cyclin B1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CCNB1 mRNA CTD PMID:37567420 NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172 		JBrowse link
G Ccnd1 cyclin D1 increases expression
multiple interactions		 ISO
EXP		 Glucose results in increased expression of CCND1; Glucose results in increased expression of CCND1 mRNA
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA]]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND1 mRNA]
resveratrol inhibits the reaction [Glucose results in increased expression of CCND1 protein]
[Glucose co-treated with resveratrol] results in decreased expression of CCND1 mRNA; resveratrol inhibits the reaction [Glucose results in increased expression of CCND1 mRNA]		 CTD PMID:23690508 PMID:24064760 PMID:24971582 PMID:27049278 PMID:27481074 NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602 		JBrowse link
G Ccnd2 cyclin D2 multiple interactions ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA]]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CCND2 mRNA] CTD PMID:27481074 NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495 		JBrowse link
G Ccne1 cyclin E1 increases expression
multiple interactions		 EXP Glucose results in increased expression of CCNE1 protein
resveratrol inhibits the reaction [Glucose results in increased expression of CCNE1 protein]		 CTD PMID:24971582 NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101 		JBrowse link
G Ccnl1 cyclin L1 increases expression ISO Glucose results in increased expression of CCNL1 mRNA CTD PMID:17178593 NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368 		JBrowse link
G Ccr10 C-C motif chemokine receptor 10 multiple interactions
increases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CCR10 mRNA] CTD PMID:33448797 NCBI chr10:86,108,551...86,110,988
Ensembl chr10:86,108,551...86,110,988 		JBrowse link
G Ccr6 C-C motif chemokine receptor 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CCR6 mRNA CTD PMID:37567420 NCBI chr 1:52,474,477...52,508,301
Ensembl chr 1:52,474,168...52,498,603 		JBrowse link
G Ccr7 C-C motif chemokine receptor 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CCR7 mRNA CTD PMID:37567420 NCBI chr10:84,098,193...84,108,309
Ensembl chr10:84,097,381...84,108,309 		JBrowse link
G Ccs copper chaperone for superoxide dismutase multiple interactions EXP [Glucose co-treated with Lycopene] results in increased expression of CCS mRNA CTD PMID:38444079 NCBI chr 1:202,113,792...202,134,931
Ensembl chr 1:202,113,804...202,134,915 		JBrowse link
G Cd14 CD14 molecule multiple interactions ISO CD14 protein affects the reaction [Glucose promotes the reaction [Lipopolysaccharides results in increased secretion of MMP1 protein]]; Curcumin inhibits the reaction [Glucose promotes the reaction [Lipopolysaccharides results in increased expression of CD14 protein]]; Glucose promotes the reaction [Lipopolysaccharides results in increased expression of CD14 protein] CTD PMID:18180316 NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261 		JBrowse link
G Cd151 CD151 molecule (Raph blood group) multiple interactions EXP CD151 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 1:196,564,744...196,568,753
Ensembl chr 1:196,565,181...196,568,753 		JBrowse link
G Cd160 CD160 molecule decreases expression ISO Glucose results in decreased expression of CD160 mRNA CTD PMID:31525975 NCBI chr 2:184,340,820...184,383,421
Ensembl chr 2:184,340,599...184,375,834 		JBrowse link
G Cd163 CD163 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD163 mRNA CTD PMID:37567420 NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878 		JBrowse link
G Cd19 CD19 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CD19 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CD19 mRNA CTD PMID:37567420 NCBI chr 1:180,987,286...180,993,920
Ensembl chr 1:180,987,286...180,993,975 		JBrowse link
G Cd1d1 CD1d1 molecule multiple interactions
increases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CD1D1 mRNA] CTD PMID:33448797 NCBI chr 2:172,423,582...172,427,089
Ensembl chr 2:172,423,582...172,427,089 		JBrowse link
G Cd226 CD226 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD226 mRNA CTD PMID:37567420 NCBI chr18:82,449,924...82,545,107
Ensembl chr18:82,450,568...82,543,051 		JBrowse link
G Cd247 Cd247 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD247 mRNA CTD PMID:37567420 NCBI chr13:78,043,302...78,118,437
Ensembl chr13:78,043,307...78,122,263 		JBrowse link
G Cd300a Cd300a molecule increases expression
multiple interactions		 ISO Glucose results in increased expression of CD300A mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD300A mRNA		 CTD PMID:31525975 PMID:37567420 NCBI chr10:99,929,801...99,942,674
Ensembl chr10:99,929,801...99,942,674 		JBrowse link
G Cd300lb CD300 molecule-like family member b multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CD300LB mRNA CTD PMID:37567420 NCBI chr10:99,964,801...99,974,790
Ensembl chr10:99,964,801...99,974,790 		JBrowse link
G Cd36 CD36 molecule multiple interactions
increases expression		 ISO (R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA; Fenofibrate inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; lanifibranor inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Pioglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; Rosiglitazone inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]; saroglitazar inhibits the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in decreased expression of CD36 mRNA]
Glucose results in increased expression of CD36 mRNA		 CTD PMID:32613381 PMID:36156098 NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903 		JBrowse link
G Cd3e CD3 epsilon subunit of T-cell receptor complex multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD3E mRNA CTD PMID:37567420 NCBI chr 8:45,303,848...45,315,005
Ensembl chr 8:45,303,852...45,315,022 		JBrowse link
G Cd40lg CD40 ligand multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CD40LG mRNA CTD PMID:37567420 NCBI chr  X:135,127,052...135,138,768
Ensembl chr  X:135,126,969...135,138,306 		JBrowse link
G Cd44 CD44 molecule increases expression
multiple interactions		 ISO Glucose results in increased expression of CD44 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CD44 mRNA		 CTD PMID:17178593 PMID:37567420 NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620 		JBrowse link
G Cd48 Cd48 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD48 mRNA CTD PMID:37567420 NCBI chr13:84,184,884...84,209,144
Ensembl chr13:84,185,532...84,209,142 		JBrowse link
G Cd5 Cd5 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CD5 mRNA CTD PMID:37567420 NCBI chr 1:207,365,337...207,386,313
Ensembl chr 1:207,365,337...207,386,313 		JBrowse link
G Cd52 CD52 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD52 mRNA CTD PMID:37567420 NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348 		JBrowse link
G Cd6 Cd6 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD6 mRNA CTD PMID:37567420 NCBI chr 1:207,442,873...207,481,703
Ensembl chr 1:207,442,877...207,481,634 		JBrowse link
G Cd74 CD74 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CD74 mRNA CTD PMID:37567420 NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003 		JBrowse link
G Cd8b CD8 subunit beta multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD8B1 mRNA CTD PMID:37567420 NCBI chr 4:103,312,596...103,328,523
Ensembl chr 4:103,312,578...103,328,553 		JBrowse link
G Cd96 CD96 molecule multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CD96 mRNA CTD PMID:37567420 NCBI chr11:54,702,290...54,776,618
Ensembl chr11:54,702,290...54,776,621 		JBrowse link
G Cdc42 cell division cycle 42 increases expression
multiple interactions		 ISO Glucose results in increased expression of CDC42 mRNA; Glucose results in increased expression of CDC42 protein
Eucalyptol inhibits the reaction [Glucose results in increased expression of CDC42 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDC42 mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDC42 protein]		 CTD PMID:24659233 PMID:31483951 NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111 		JBrowse link
G Cdh1 cadherin 1 multiple interactions
decreases expression		 ISO 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in decreased expression of CDH1 protein]; [Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein]; DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 protein]; MAPK14 protein promotes the reaction [[Glucose co-treated with TGFB1 protein] results in decreased expression of CDH1 protein]; MAPK14 protein promotes the reaction [Glucose results in decreased expression of CDH1 protein]
Glucose results in decreased expression of CDH1 mRNA; Glucose results in decreased expression of CDH1 protein		 CTD PMID:21829520 PMID:26045780 PMID:29163160 PMID:33992720 PMID:35445903 More... NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775 		JBrowse link
G Cdh5 cadherin 5 decreases expression ISO Glucose results in decreased expression of CDH5 mRNA CTD PMID:31655124 NCBI chr19:815,415...854,478
Ensembl chr19:815,411...854,368 		JBrowse link
G Cdk1 cyclin-dependent kinase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CDK1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CDK1 mRNA CTD PMID:37567420 NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408 		JBrowse link
G Cdk9 cyclin-dependent kinase 9 increases phosphorylation
multiple interactions		 ISO Glucose results in increased phosphorylation of CDK9 protein
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased phosphorylation of CDK9 protein]; CDK9 protein affects the reaction [Glucose results in increased expression of COL4A4 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of IL1B mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of IL6 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of NOS2 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of TGFB1 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of TNF mRNA]; CDK9 protein affects the reaction [Glucose results in increased phosphorylation of MAPK1 protein]; CDK9 protein affects the reaction [Glucose results in increased phosphorylation of MAPK3 protein]; CDK9 protein affects the reaction [Glucose results in increased secretion of IL6 protein]; CDK9 protein affects the reaction [Glucose results in increased secretion of TNF protein]		 CTD PMID:33631230 NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:15,996,468...16,002,410 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
decreases expression
multiple interactions		 ISO
EXP		 Glucose results in increased expression of CDKN1A mRNA
Glucose results in decreased expression of CDKN1A protein
Glucose promotes the reaction [SETD7 protein binds to CDKN1A promoter]; NAD inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; TGFB1 protein promotes the reaction [Glucose promotes the reaction [SETD7 protein binds to CDKN1A promoter]]; TGFB1 protein promotes the reaction [Glucose results in increased expression of CDKN1A mRNA]
Glucose results in increased expression of CDKN1A mRNA; Glucose results in increased expression of CDKN1A protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A mRNA]]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A protein]]; [Glucose co-treated with Deferoxamine] results in increased expression of CDKN1A mRNA; [Palmitic Acid co-treated with Glucose] results in increased expression of CDKN1A mRNA; CDKN1A protein affects the reaction [Glucose results in increased expression of GLB1 protein]; Fluorometholone inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1A mRNA]; Melatonin inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A mRNA]; Phytic Acid inhibits the reaction [Glucose results in increased expression of CDKN1A protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1A mRNA]; SIRT1 protein mutant form inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased expression of CDKN1A mRNA]; TAS1R1 protein affects the reaction [Glucose results in decreased expression of CDKN1A protein]		 CTD PMID:17178593 PMID:22561310 PMID:24451382 PMID:27049278 PMID:27652271 More... NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585 		JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B increases expression
multiple interactions		 EXP
ISO		 Glucose results in increased expression of CDKN1B protein
[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA]
NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]; Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]; Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; SIRT1 protein promotes the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]]		 CTD PMID:22561310 PMID:33962019 PMID:33992720 NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982 		JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A increases expression
multiple interactions		 ISO
EXP		 Glucose results in increased expression of CDKN2A protein; Glucose results in increased expression of CDKN2A protein alternative form
CDKN2A protein affects the reaction [Glucose results in increased expression of GLB1 protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of CDKN2A protein alternative form]		 CTD PMID:23494737 PMID:38483099 NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149 		JBrowse link
G Ceacam1 CEA cell adhesion molecule 1 multiple interactions
decreases expression
decreases secretion		 ISO cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of CEACAM1 mRNA]; cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased secretion of CEACAM1 protein] CTD PMID:19924377 NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992 		JBrowse link
G Ceacam19 CEA cell adhesion molecule 19 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CEACAM19 mRNA CTD PMID:37567420 NCBI chr 1:79,542,107...79,550,927
Ensembl chr 1:79,542,107...79,550,927 		JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha multiple interactions ISO CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPA protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; Glucose promotes the reaction [CEBPA protein binds to EDN1 promoter]; Glucose results in increased localization of and results in increased activity of CEBPA protein; pyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein]; SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein]; U 0126 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein] CTD PMID:24376792 NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta multiple interactions
decreases expression		 ISO CEBPB protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPB protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; Glucose promotes the reaction [CEBPB protein binds to EDN1 promoter]; Glucose results in increased localization of and results in increased activity of CEBPB protein; pyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPB protein]; SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPB protein]; U 0126 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPB protein]
CEBPB protein inhibits the reaction [Glucose results in decreased expression of ACE2 protein]; CEBPB protein inhibits the reaction [Glucose results in decreased expression of and results in decreased activity of MMP2 protein]; CEBPB protein inhibits the reaction [Glucose results in decreased expression of MAS1 protein]; CEBPB protein inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of ACE protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR1 protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of AGTR2 protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of BAX protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of COL3A1 protein]; CEBPB protein inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; Glucose inhibits the reaction [CEBPB protein binds to ACE2 promoter]
Glucose results in decreased expression of CEBPB protein		 CTD PMID:24376792 PMID:28482072 PMID:29266779 NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta multiple interactions ISO CEBPD protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPD protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; Glucose promotes the reaction [CEBPD protein binds to EDN1 promoter]; Glucose results in increased localization of and results in increased activity of CEBPD protein; pyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein]; SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein]; U 0126 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPD protein] CTD PMID:24376792 NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829 		JBrowse link
G Celf3 CUGBP, Elav-like family member 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of CELF3 mRNA CTD PMID:37567420 NCBI chr 2:182,116,034...182,130,163
Ensembl chr 2:182,116,073...182,130,163 		JBrowse link
G Celf4 CUGBP, Elav-like family member 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CELF4 mRNA CTD PMID:37567420 NCBI chr18:16,786,578...17,065,045
Ensembl chr18:16,786,867...17,064,786 		JBrowse link
G Celsr1 cadherin, EGF LAG seven-pass G-type receptor 1 multiple interactions
increases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CELSR1 mRNA] CTD PMID:33448797 NCBI chr 7:116,987,616...117,125,035
Ensembl chr 7:116,987,605...117,125,164 		JBrowse link
G Celsr3 cadherin, EGF LAG seven-pass G-type receptor 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CELSR3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CELSR3 mRNA CTD PMID:37567420 NCBI chr 8:109,530,597...109,558,360
Ensembl chr 8:109,530,641...109,558,354 		JBrowse link
G Cemip cell migration inducing hyaluronidase 1 multiple interactions
increases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CEMIP mRNA] CTD PMID:33448797 NCBI chr 1:137,906,921...138,062,430
Ensembl chr 1:137,908,920...138,062,415 		JBrowse link
G Cenpf centromere protein F multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CENPF mRNA CTD PMID:37567420 NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669 		JBrowse link
G Cert1 ceramide transporter 1 multiple interactions
increases expression		 EXP rhodioloside inhibits the reaction [Glucose results in increased expression of CERT1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of CERT1 mRNA] CTD PMID:29031534 NCBI chr 2:27,882,546...27,987,090
Ensembl chr 2:27,882,555...27,987,074 		JBrowse link
G Ces2f carboxylesterase 2F increases expression ISO Glucose results in increased expression of CES2F mRNA CTD PMID:31525975 NCBI chr19:7,527...14,898
Ensembl chr19:7,527...14,898 		JBrowse link
G Ces2h carboxylesterase 2H multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CES2H mRNA CTD PMID:37567420 NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830 		JBrowse link
G Cfap45 cilia and flagella associated protein 45 increases expression ISO Glucose results in increased expression of CFAP45 mRNA CTD PMID:31525975 NCBI chr13:84,989,474...85,012,880
Ensembl chr13:84,981,728...85,012,878 		JBrowse link
G Cfap74 cilia and flagella associated protein 74 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CFAP74 mRNA CTD PMID:37567420 NCBI chr 5:165,970,611...166,046,068
Ensembl chr 5:165,979,805...166,046,071 		JBrowse link
G Cfap97d1 CFAP97 domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CFAP97D1 mRNA CTD PMID:37567420 NCBI chr10:86,933,585...86,944,566
Ensembl chr10:86,933,808...86,938,244 		JBrowse link
G Cfd complement factor D decreases expression
multiple interactions		 EXP
ISO		 Glucose results in decreased expression of CFD mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CFD mRNA		 CTD PMID:3299706 PMID:37567420 NCBI chr 7:9,813,148...9,814,871
Ensembl chr 7:9,813,150...9,815,053 		JBrowse link
G Cfl1 cofilin 1 increases secretion ISO Glucose deficiency results in increased secretion of CFL1 protein CTD PMID:24802182 NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587 		JBrowse link
G Cfp complement factor properdin decreases expression
multiple interactions		 ISO Glucose results in decreased expression of CFP mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of CFP mRNA]		 CTD PMID:33448797 NCBI chr  X:1,162,014...1,167,576
Ensembl chr  X:1,161,979...1,167,573 		JBrowse link
G Chac1 ChaC glutathione-specific gamma-glutamylcyclotransferase 1 multiple interactions EXP CHAC1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526 		JBrowse link
G Chd2 chromodomain helicase DNA binding protein 2 multiple interactions ISO Glucose promotes the reaction [TCF19 protein binds to CHD2 protein] CTD PMID:29042441 NCBI chr 1:127,188,146...127,317,041
Ensembl chr 1:127,190,059...127,300,502 		JBrowse link
G Chgb chromogranin B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CHGB mRNA CTD PMID:37567420 NCBI chr 3:120,043,824...120,057,169
Ensembl chr 3:120,043,738...120,057,166 		JBrowse link
G Chkb choline kinase beta multiple interactions EXP CHKB protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 7:120,500,960...120,504,359
Ensembl chr 7:120,500,984...120,504,461 		JBrowse link
G Chrdl2 chordin-like 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CHRDL2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CHRDL2 mRNA CTD PMID:37567420 NCBI chr 1:154,343,201...154,370,651
Ensembl chr 1:154,343,201...154,370,640 		JBrowse link
G Chrm2 cholinergic receptor, muscarinic 2 increases expression EXP Glucose results in increased expression of CHRM2 mRNA CTD PMID:18715473 NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103 		JBrowse link
G Chrna2 cholinergic receptor nicotinic alpha 2 subunit multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CHRNA2 mRNA CTD PMID:37567420 NCBI chr15:40,342,317...40,358,601
Ensembl chr15:40,342,317...40,358,601 		JBrowse link
G Cimap1c ciliary microtubule associated protein 1C multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CIMAP1C mRNA CTD PMID:37567420 NCBI chr 8:57,248,746...57,281,084
Ensembl chr 8:57,248,746...57,281,004 		JBrowse link
G Ckap2 cytoskeleton associated protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CKAP2 mRNA CTD PMID:37567420 NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913 		JBrowse link
G Ckb creatine kinase B multiple interactions
increases activity		 ISO Glucose inhibits the reaction [daidzein results in increased activity of CKB protein]; Glucose inhibits the reaction [Dihydrotestosterone results in increased activity of CKB protein]; Glucose inhibits the reaction [Estradiol results in increased activity of CKB protein]; Glucose inhibits the reaction [Genistein results in increased activity of CKB protein]
Glucose results in increased activity of CKB protein		 CTD PMID:16621514 NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315 		JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 increases expression ISO Glucose results in increased expression of CKS2 mRNA CTD PMID:17178593 NCBI chr17:13,570,611...13,575,770 JBrowse link
G Clec4a C-type lectin domain family 4, member A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CLEC4N mRNA CTD PMID:37567420 NCBI chr 4:156,340,439...156,434,212
Ensembl chr 4:156,414,688...156,432,402 		JBrowse link
G Clec4e C-type lectin domain family 4, member E multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CLEC4E mRNA CTD PMID:37567420 NCBI chr 4:156,606,927...156,612,911
Ensembl chr 4:156,607,614...156,612,767 		JBrowse link
G Clhc1 clathrin heavy chain linker domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CLHC1 mRNA CTD PMID:37567420 NCBI chr14:103,288,116...103,328,725
Ensembl chr14:103,288,134...103,328,715 		JBrowse link
G Clic6 chloride intracellular channel 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CLIC6 mRNA CTD PMID:37567420 NCBI chr11:31,737,813...31,780,360
Ensembl chr11:31,737,813...31,780,061 		JBrowse link
G Clspn claspin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CLSPN mRNA CTD PMID:37567420 NCBI chr 5:138,850,119...138,885,037
Ensembl chr 5:138,850,128...138,885,034 		JBrowse link
G Clstn3 calsyntenin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CLSTN3 mRNA CTD PMID:37567420 NCBI chr 4:157,331,494...157,364,769
Ensembl chr 4:157,331,494...157,364,769 		JBrowse link
G Cma1 chymase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CMA1 mRNA CTD PMID:37567420 NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233 		JBrowse link
G Cnih2 cornichon family AMPA receptor auxiliary protein 2 increases expression ISO Glucose results in increased expression of CNIH2 mRNA CTD PMID:17178593 NCBI chr 1:202,399,416...202,405,110
Ensembl chr 1:202,399,419...202,405,089 		JBrowse link
G Cnn1 calponin 1 increases methylation
decreases expression
multiple interactions		 ISO Glucose results in increased methylation of CNN1 gene
Glucose results in decreased expression of CNN1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of CNN1 mRNA]		 CTD PMID:33448797 NCBI chr 8:20,632,434...20,641,097
Ensembl chr 8:20,632,338...20,641,098 		JBrowse link
G Cnr1 cannabinoid receptor 1 decreases expression
multiple interactions
increases expression		 EXP Glucose results in decreased expression of CNR1 mRNA
MIR29A mRNA inhibits the reaction [Glucose results in increased expression of CNR1 mRNA]; MIR29A mRNA inhibits the reaction [Glucose results in increased expression of CNR1 protein]
Glucose results in increased expression of CNR1 mRNA; Glucose results in increased expression of CNR1 protein		 CTD PMID:19501110 PMID:30642005 NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:48,408,574...48,435,099 		JBrowse link
G Cntn4 contactin 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CNTN4 mRNA CTD PMID:37567420 NCBI chr 4:138,624,584...139,622,499
Ensembl chr 4:139,099,152...139,621,090 		JBrowse link
G Cntnap2 contactin associated protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CNTNAP2 mRNA CTD PMID:37567420 NCBI chr 4:74,109,455...76,366,434
Ensembl chr 4:74,109,472...76,362,027 		JBrowse link
G Cntnap5b contactin associated protein family member 5B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CNTNAP5A mRNA CTD PMID:37567420 NCBI chr13:17,863,367...18,766,983
Ensembl chr13:18,093,420...18,761,014 		JBrowse link
G Col19a1 collagen type XIX alpha 1 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL19A1 mRNA CTD PMID:37567420 NCBI chr 9:26,673,916...27,022,139
Ensembl chr 9:26,675,391...27,022,106 		JBrowse link
G Col1a1 collagen type I alpha 1 chain affects secretion
decreases expression
increases expression
multiple interactions		 ISO
EXP		 Glucose deficiency affects the secretion of COL1A1 protein
Glucose results in decreased expression of COL1A1 mRNA
Glucose results in increased expression of COL1A1 mRNA; Glucose results in increased expression of COL1A1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in decreased expression of COL1A1 mRNA]]; DKK1 protein inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA]; Melatonin inhibits the reaction [Glucose results in decreased expression of COL1A1 mRNA]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL1A1 protein]]; MIR142 inhibits the reaction [Glucose results in increased expression of COL1A1 protein]; Phytic Acid inhibits the reaction [Glucose results in decreased expression of COL1A1 mRNA]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of COL1A1 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL1A1 protein]
Curcumin analog inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA]		 CTD PMID:24802182 PMID:28700904 PMID:29163160 PMID:38000455 PMID:38124441 NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624 		JBrowse link
G Col1a2 collagen type I alpha 2 chain multiple interactions
increases secretion
increases expression		 ISO troglitazone inhibits the reaction [Glucose results in increased expression of COL1A2 mRNA]
Glucose deficiency results in increased secretion of COL1A2 protein		 CTD PMID:17199790 PMID:24802182 NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867 		JBrowse link
G Col27a1 collagen type XXVII alpha 1 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of COL27A1 mRNA CTD PMID:37567420 NCBI chr 5:76,647,302...76,765,989
Ensembl chr 5:76,647,429...76,765,174 		JBrowse link
G Col3a1 collagen type III alpha 1 chain affects secretion
increases expression
multiple interactions		 ISO Glucose deficiency affects the secretion of COL3A1 protein
Glucose results in increased expression of COL3A1 protein
CEBPB protein inhibits the reaction [Glucose results in increased expression of COL3A1 protein]; Valsartan inhibits the reaction [Glucose results in increased expression of COL3A1 protein]		 CTD PMID:24802182 PMID:29266779 NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547 		JBrowse link
G Col4a1 collagen type IV alpha 1 chain multiple interactions
increases expression		 EXP
ISO		 [eplerenone co-treated with Enalapril] inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]; Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]; Curcumin analog inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA]; Enalapril inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]; eplerenone inhibits the reaction [Aldosterone promotes the reaction [Glucose results in increased expression of COL4A1 mRNA]]
MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL4A1 protein]]; MIR142 inhibits the reaction [Glucose results in increased expression of COL4A1 protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of COL4A1 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of COL4A1 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA]]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of COL4A1 mRNA]		 CTD PMID:18682491 PMID:28700904 PMID:33270355 PMID:38124441 NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412 		JBrowse link
G Col4a2 collagen type IV alpha 2 chain affects secretion ISO Glucose deficiency affects the secretion of COL4A2 protein CTD PMID:24802182 NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839 		JBrowse link
G Col4a4 collagen type IV alpha 4 chain increases expression
multiple interactions		 ISO Glucose results in increased expression of COL4A4 mRNA
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide inhibits the reaction [Glucose results in increased expression of COL4A4 mRNA]; CDK9 protein affects the reaction [Glucose results in increased expression of COL4A4 mRNA]		 CTD PMID:33631230 NCBI chr 9:83,833,173...83,875,436
Ensembl chr 9:83,755,515...83,875,876 		JBrowse link
G Col5a1 collagen type V alpha 1 chain affects secretion ISO Glucose deficiency affects the secretion of COL5A1 protein CTD PMID:24802182 NCBI chr 3:11,208,429...11,356,715
Ensembl chr 3:11,208,512...11,354,588 		JBrowse link
G Col5a2 collagen type V alpha 2 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL5A2 mRNA CTD PMID:37567420 NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154 		JBrowse link
G Col6a1 collagen type VI alpha 1 chain affects secretion ISO Glucose deficiency affects the secretion of COL6A1 protein CTD PMID:24802182 NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597 		JBrowse link
G Col6a2 collagen type VI alpha 2 chain affects secretion ISO Glucose deficiency affects the secretion of COL6A2 protein CTD PMID:24802182 NCBI chr20:12,021,676...12,049,425
Ensembl chr20:12,021,767...12,057,564 		JBrowse link
G Col6a5 collagen type VI alpha 5 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of COL6A5 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL6A5 mRNA CTD PMID:37567420 NCBI chr 8:106,483,806...106,584,114
Ensembl chr 8:106,483,799...106,584,113 		JBrowse link
G Col6a6 collagen type VI alpha 6 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of COL6A6 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of COL6A6 mRNA CTD PMID:37567420 NCBI chr 8:106,318,010...106,473,419
Ensembl chr 8:106,306,422...106,473,472 		JBrowse link
G Col7a1 collagen type VII alpha 1 chain multiple interactions
decreases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of COL7A1 mRNA] CTD PMID:33448797 NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252 		JBrowse link
G Col8a2 collagen type VIII alpha 2 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of COL8A2 mRNA CTD PMID:37567420 NCBI chr 5:138,586,201...138,613,627
Ensembl chr 5:138,585,999...138,612,850 		JBrowse link
G Commd9 COMM domain containing 9 multiple interactions EXP COMMD9 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 3:88,175,909...88,190,427
Ensembl chr 3:88,175,987...88,190,439 		JBrowse link
G Cox4i1 cytochrome c oxidase subunit 4i1 increases expression
multiple interactions		 ISO Glucose deficiency results in increased expression of COX4I1 mRNA
[Glucose co-treated with Palmitic Acid] results in decreased expression of COX4I1 mRNA		 CTD PMID:26811028 PMID:39265716 NCBI chr19:48,721,680...48,727,920
Ensembl chr19:48,721,199...48,727,921 		JBrowse link
G Cox5b cytochrome c oxidase subunit 5B multiple interactions EXP COX5B protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052 		JBrowse link
G Cox6a2 cytochrome c oxidase subunit 6A2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of COX6A2 mRNA CTD PMID:37567420 NCBI chr 1:182,788,528...182,790,746
Ensembl chr 1:182,788,528...182,789,274 		JBrowse link
G Cpe carboxypeptidase E multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CPE mRNA CTD PMID:37567420 NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233 		JBrowse link
G Cpq carboxypeptidase Q multiple interactions
decreases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of CPQ mRNA] CTD PMID:33448797 NCBI chr 7:64,264,025...64,830,867
Ensembl chr 7:64,264,081...64,724,546 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A decreases expression
multiple interactions		 ISO Glucose results in decreased expression of CPT1A protein
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA; Bezafibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Ditiocarb inhibits the reaction [YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of CPT1A protein]]]]; Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of CPT1A protein]; Fenofibrate affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of CPT1A protein]]; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Pioglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of CPT1A mRNA]; YY1 protein inhibits the reaction [jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in decreased expression of CPT1A protein]]]
Glucose results in decreased expression of CPT1A mRNA; Glucose results in decreased expression of CPT1A protein		 CTD PMID:23090186 PMID:32613381 PMID:36156098 PMID:39059604 NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055 		JBrowse link
G Cpt2 carnitine palmitoyltransferase 2 affects expression
multiple interactions		 EXP
ISO		 Glucose affects the expression of CPT2 mRNA
[Glucose co-treated with Palmitic Acid] results in decreased expression of CPT2 mRNA		 CTD PMID:24349266 PMID:39265716 NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 increases activity
multiple interactions		 ISO
EXP		 Glucose results in increased activity of CREB1 protein
[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased phosphorylation of CREB1 protein; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Oxygen co-treated with Glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased phosphorylation of CREB1 protein]		 CTD PMID:15767253 PMID:24726522 NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816 		JBrowse link
G Creb3l3 cAMP responsive element binding protein 3-like 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CREB3L3 mRNA CTD PMID:37567420 NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048 		JBrowse link
G Crlf1 cytokine receptor-like factor 1 multiple interactions
increases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CRLF1 mRNA] CTD PMID:33448797 NCBI chr16:18,924,722...18,936,049
Ensembl chr16:18,924,722...18,935,997 		JBrowse link
G Crmp1 collapsin response mediator protein 1 multiple interactions EXP CRMP1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr14:73,509,933...73,556,192
Ensembl chr14:73,509,933...73,556,177 		JBrowse link
G Crtac1 cartilage acidic protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CRTAC1 mRNA CTD PMID:37567420 NCBI chr 1:241,091,679...241,233,677
Ensembl chr 1:241,078,864...241,233,421 		JBrowse link
G Cryaa crystallin, alpha A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CRYAA mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CRYAA mRNA CTD PMID:37567420 NCBI chr20:9,783,605...9,787,351
Ensembl chr20:9,783,605...9,787,349 		JBrowse link
G Crybg2 crystallin beta-gamma domain containing 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CRYBG2 mRNA CTD PMID:37567420 NCBI chr 5:146,286,406...146,318,417
Ensembl chr 5:146,286,925...146,323,666 		JBrowse link
G Cs citrate synthase increases activity
multiple interactions		 ISO Glucose results in increased activity of CS protein
Desipramine inhibits the reaction [Glucose results in increased activity of CS protein]		 CTD PMID:32481596 NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421 		JBrowse link
G Csrnp1 cysteine and serine rich nuclear protein 1 increases expression ISO Glucose results in increased expression of CSRNP1 mRNA CTD PMID:17178593 NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183 		JBrowse link
G Cst6 cystatin E/M multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of CST6 mRNA CTD PMID:37567420 NCBI chr 1:202,655,322...202,657,030
Ensembl chr 1:202,655,322...202,657,030 		JBrowse link
G Cth cystathionine gamma-lyase decreases expression EXP Glucose deficiency results in decreased expression of CTH mRNA; Glucose deficiency results in decreased expression of CTH protein CTD PMID:35577173 NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234 		JBrowse link
G Ctnnb1 catenin beta 1 decreases expression
affects localization
multiple interactions
increases expression		 EXP
ISO		 Glucose results in decreased expression of CTNNB1 mRNA; Glucose results in decreased expression of CTNNB1 protein
Glucose affects the localization of CTNNB1 protein
[Glucose co-treated with ICG 001] results in decreased expression of CTNNB1 protein; [ICG 001 co-treated with Glucose] affects the localization of CTNNB1 protein; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [[Glucose co-treated with ICG 001] results in decreased expression of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [[ICG 001 co-treated with Glucose] affects the localization of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [Glucose affects the localization of CTNNB1 protein]; Panax notoginseng extract inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein]
Glucose results in increased expression of CTNNB1 mRNA; Glucose results in increased expression of CTNNB1 protein
Simvastatin inhibits the reaction [Glucose results in decreased expression of CTNNB1 protein]		 CTD PMID:18004065 PMID:21818840 PMID:29163160 PMID:35385194 NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111 		JBrowse link
G Ctsb cathepsin B multiple interactions
increases expression		 ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CTSB protein; Melatonin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CTSB protein]
Glucose results in increased expression of CTSB mRNA		 CTD PMID:17178593 PMID:21392095 NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500 		JBrowse link
G Ctsl cathepsin L increases secretion ISO Glucose deficiency results in increased secretion of CTSL protein CTD PMID:24802182 NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548 		JBrowse link
G Ctsw cathepsin W multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CTSW mRNA CTD PMID:37567420 NCBI chr 1:202,772,395...202,777,021
Ensembl chr 1:202,772,572...202,775,964 		JBrowse link
G Cttn cortactin decreases expression
multiple interactions		 ISO Glucose results in decreased expression of CTTN protein
Eucalyptol inhibits the reaction [Glucose results in decreased expression of CTTN protein]		 CTD PMID:31483951 NCBI chr 1:199,599,710...199,635,254
Ensembl chr 1:199,599,710...199,635,164 		JBrowse link
G Cx3cl1 C-X3-C motif chemokine ligand 1 multiple interactions
increases expression		 ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]; Clofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; Clofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; Fenofibrate inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]; SB 203580 inhibits the reaction [Glucose results in increased expression of CX3CL1 mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of CX3CL1 protein]
Glucose results in increased expression of CX3CL1 mRNA; Glucose results in increased expression of CX3CL1 protein		 CTD PMID:19132243 PMID:31655124 NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression
multiple interactions		 ISO Glucose results in increased expression of CXCL10 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CXCL10 mRNA		 CTD PMID:17178593 PMID:37567420 NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 increases expression ISO Glucose results in increased expression of CXCL2 mRNA CTD PMID:17178593 NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 increases expression
multiple interactions		 ISO Glucose results in increased expression of CXCL1 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CXCL1 mRNA		 CTD PMID:17178593 PMID:37567420 NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511 		JBrowse link
G Cxcl9 C-X-C motif chemokine ligand 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CXCL9 mRNA CTD PMID:37567420 NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 multiple interactions ISO [Glucose co-treated with Oxygen deficiency] results in decreased expression of CXCR4 mRNA; [Glucose co-treated with Oxygen deficiency] results in decreased expression of CXCR4 protein CTD PMID:18227068 NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883 		JBrowse link
G Cyba cytochrome b-245 alpha chain increases expression
decreases expression
multiple interactions		 ISO
EXP		 Glucose results in increased expression of CYBA protein
Glucose results in decreased expression of CYBA mRNA
Glucose results in increased expression of CYBA mRNA; Glucose results in increased expression of CYBA protein
[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein; [[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species; CYBA protein promotes the reaction [Glucose results in increased chemical synthesis of Reactive Oxygen Species]; CYBA protein promotes the reaction [Glucose results in increased expression of FN1 protein]; farrerol inhibits the reaction [Glucose results in increased expression of CYBA mRNA]; farrerol inhibits the reaction [Glucose results in increased expression of CYBA protein]; pyrazolanthrone inhibits the reaction [Glucose results in increased expression of CYBA protein]; Resveratrol inhibits the reaction [[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of CYBA mRNA]; Resveratrol inhibits the reaction [Glucose results in increased expression of CYBA protein]
dorsomorphin inhibits the reaction [Rosiglitazone inhibits the reaction [Glucose results in increased expression of CYBA protein]]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in increased expression of CYBA protein]; Rosiglitazone inhibits the reaction [Glucose results in increased expression of CYBA protein]		 CTD PMID:17916771 PMID:18088078 PMID:22245600 PMID:31838053 PMID:32942007 NCBI chr19:50,487,598...50,495,669
Ensembl chr19:50,487,597...50,495,721 		JBrowse link
G Cybb cytochrome b-245 beta chain multiple interactions
increases expression
increases localization		 ISO
EXP		 acetovanillone inhibits the reaction [Glucose results in increased expression of and results in increased activity of CYBB protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of CYBB protein]; Glucose results in increased expression of and results in increased activity of CYBB protein; Telmisartan inhibits the reaction [Glucose results in increased expression of CYBB mRNA]; Telmisartan inhibits the reaction [Glucose results in increased expression of CYBB protein]
Glucose results in increased expression of CYBB mRNA; Glucose results in increased expression of CYBB protein
dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein]]; Resveratrol inhibits the reaction [Glucose results in increased expression of CYBB protein]
Glucose results in increased localization of CYBB protein
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein; Prodigiosin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein]; prolinedithiocarbamate inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of CYBB protein]		 CTD PMID:19878672 PMID:21925195 PMID:22253932 PMID:26054749 PMID:31494106 More... NCBI chr  X:13,358,101...13,392,570
Ensembl chr  X:13,359,430...13,392,586 		JBrowse link
G Cycs cytochrome c, somatic affects localization
multiple interactions
increases expression		 EXP
ISO		 Glucose affects the localization of CYCS protein
naringenin inhibits the reaction [Glucose affects the localization of CYCS protein]; Scopoletin inhibits the reaction [Glucose results in increased expression of CYCS protein]
Glucose results in increased expression of CYCS mRNA; Glucose results in increased expression of CYCS protein
[Glucose co-treated with Deferoxamine] results in increased expression of CYCS mRNA; diallyl trisulfide inhibits the reaction [Glucose results in increased expression of CYCS protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CYCS mRNA]; MitoTEMPO inhibits the reaction [Glucose results in increased expression of CYCS protein]		 CTD PMID:23192364 PMID:31115753 PMID:33962019 PMID:37619648 NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054
Ensembl chr18:79,651,378...79,654,054 		JBrowse link
G Cygb cytoglobin decreases expression ISO Glucose results in decreased expression of CYGB mRNA CTD PMID:32942007 NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442 		JBrowse link
G Cyp11b3 cytochrome P450, family 11, subfamily b, polypeptide 3 decreases expression EXP Glucose results in decreased expression of CYP11B2 mRNA CTD PMID:15017115 NCBI chr 7:106,808,559...106,814,048
Ensembl chr 7:106,808,559...106,814,048 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression		 ISO Polyphenols promotes the reaction [Glucose results in increased expression of CYP1A1 mRNA]
CYP1A1 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]]		 CTD PMID:21682256 PMID:31776611 NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions ISO CYP1A2 protein affects the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased secretion of INS1 protein]] CTD PMID:31776611 NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions ISO [Oxygen co-treated with Glucose] inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein]; [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of CYP1B1 protein CTD PMID:28400208 NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917 		JBrowse link
G Cyp26b1 cytochrome P450, family 26, subfamily b, polypeptide 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of CYP26B1 mRNA CTD PMID:37567420 NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628 		JBrowse link
G Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CYP27B1 mRNA CTD PMID:37567420 NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CYP2B10 mRNA CTD PMID:37567420 NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions
increases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of CYP2E1 mRNA]
Glucose results in increased expression of CYP2E1 protein
Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of CYP2E1 protein]; jujuboside A inhibits the reaction [Fatty Acids, Nonesterified promotes the reaction [Glucose results in increased expression of CYP2E1 protein]]		 CTD PMID:33448797 PMID:39059604 NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of CYP3A13 mRNA CTD PMID:37567420 NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422 		JBrowse link
G Cyp7b1 cytochrome P450 family 7 subfamily B member 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of CYP7B1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of CYP7B1 mRNA CTD PMID:37567420 NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698 		JBrowse link
G Cysrt1 cysteine rich tail 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of CYSRT1 mRNA CTD PMID:37567420 NCBI chr 3:8,054,195...8,057,846
Ensembl chr 3:8,053,482...8,059,721 		JBrowse link
G Daxx death-domain associated protein multiple interactions
affects localization		 ISO Glucose deficiency promotes the reaction [DAXX protein binds to MAP3K5 protein]
Glucose deficiency affects the localization of DAXX protein		 CTD PMID:14505347 NCBI chr20:4,970,090...4,976,145
Ensembl chr20:4,970,092...4,975,843 		JBrowse link
G Dbi diazepam binding inhibitor increases expression ISO Glucose results in increased expression of DBI mRNA CTD PMID:17178593 NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693 		JBrowse link
G Dbn1 drebrin 1 decreases expression
multiple interactions		 EXP Glucose results in decreased expression of DBN1 mRNA; Glucose results in decreased expression of DBN1 protein
Curcumin inhibits the reaction [Glucose results in decreased expression of DBN1 mRNA]		 CTD PMID:23333261 NCBI chr17:9,150,608...9,164,982
Ensembl chr17:9,150,659...9,164,984 		JBrowse link
G Dbp D-box binding PAR bZIP transcription factor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of DBP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DBP mRNA CTD PMID:37567420 NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745 		JBrowse link
G Dclk1 doublecortin-like kinase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DCLK1 mRNA CTD PMID:37567420 NCBI chr 2:139,417,234...139,710,956
Ensembl chr 2:139,417,163...139,710,956 		JBrowse link
G Dcx doublecortin increases expression ISO Glucose results in increased expression of DCX protein CTD PMID:23776576 NCBI chr  X:107,430,767...107,573,612
Ensembl chr  X:107,430,767...107,507,476 		JBrowse link
G Ddias DNA damage-induced apoptosis suppressor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DDIAS mRNA CTD PMID:37567420 NCBI chr 1:146,906,150...146,930,462
Ensembl chr 1:146,906,154...146,930,462 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 decreases expression
multiple interactions
increases expression		 ISO
EXP		 Glucose results in decreased expression of DDIT3 mRNA
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; Metformin inhibits the reaction [Glucose results in increased expression of DDIT3 protein]
[Galactose co-treated with Glucose deficiency] promotes the reaction [leflunomide results in increased expression of DDIT3 protein]
2-aminoethoxydiphenyl borate inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; DDIT3 affects the reaction [Glucose results in decreased expression of PPARGC1A mRNA]; Gadolinium inhibits the reaction [Glucose results in increased expression of DDIT3 protein]; Glucose inhibits the reaction [DDIT3 protein binds to PPARGC1A promoter]; TRPM7 protein affects the reaction [Glucose results in increased expression of DDIT3 protein]; waixenicin A inhibits the reaction [Glucose results in increased expression of DDIT3 protein]
Glucose deficiency results in increased expression of DDIT3 mRNA; Glucose results in increased expression of DDIT3 mRNA; Glucose results in increased expression of DDIT3 protein
Glucose deficiency results in increased expression of DDIT3 protein; Glucose results in increased expression of DDIT3 protein		 CTD PMID:17178593 PMID:21337367 PMID:24349266 PMID:27226639 PMID:28482072 More... NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201 		JBrowse link
G Ddx3x DEAD-box helicase 3, X-linked increases degradation ISO Glucose deficiency results in increased degradation of DDX3X protein CTD PMID:30821613 NCBI chr  X:9,479,532...9,493,169
Ensembl chr  X:9,479,532...9,493,168 		JBrowse link
G Defb24 defensin beta 24 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of DEFB19 mRNA CTD PMID:37567420 NCBI chr 3:141,046,571...141,052,706
Ensembl chr 3:141,046,564...141,052,753 		JBrowse link
G Dek DEK proto-oncogene multiple interactions ISO DEK protein affects the chemical synthesis of and affects the uptake of Glucose CTD PMID:28558019 NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808 		JBrowse link
G Depp1 DEPP autophagy regulator 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of DEPP1 mRNA CTD PMID:37567420 NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542 		JBrowse link
G Derl3 derlin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DERL3 mRNA CTD PMID:37567420 NCBI chr20:12,754,490...12,768,454
Ensembl chr20:12,763,543...12,767,027 		JBrowse link
G Deup1 deuterosome assembly protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of DEUP1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DEUP1 mRNA CTD PMID:37567420 NCBI chr 8:12,380,300...12,442,649
Ensembl chr 8:12,380,302...12,442,199 		JBrowse link
G Dgkd diacylglycerol kinase, delta multiple interactions
affects localization		 ISO 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine inhibits the reaction [Glucose affects the localization of DGKD protein alternative form]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose affects the localization of DGKD protein alternative form] CTD PMID:22974639 NCBI chr 9:88,516,686...88,607,349
Ensembl chr 9:88,516,715...88,607,345 		JBrowse link
G Dhh desert hedgehog signaling molecule increases expression ISO Glucose results in increased expression of DHH mRNA CTD PMID:31525975 NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406 		JBrowse link
G Dhps deoxyhypusine synthase multiple interactions EXP DHPS protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr19:23,082,454...23,086,544
Ensembl chr19:23,082,448...23,086,881 		JBrowse link
G Dhrs9 dehydrogenase/reductase 9 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DHRS9 mRNA CTD PMID:37567420 NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:54,147,803...54,220,241 		JBrowse link
G Dhx58 DEXH-box helicase 58 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of DHX58 mRNA CTD PMID:37567420 NCBI chr10:85,620,352...85,631,776
Ensembl chr10:85,620,357...85,631,525 		JBrowse link
G Diablo diablo, IAP-binding mitochondrial protein multiple interactions
increases expression		 ISO [Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DIABLO mRNA]
Glucose results in increased expression of DIABLO mRNA		 CTD PMID:33962019 NCBI chr12:33,055,784...33,070,401
Ensembl chr12:33,055,263...33,070,387 		JBrowse link
G Diaph3 diaphanous-related formin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of DIAPH3 mRNA CTD PMID:37567420 NCBI chr15:62,543,375...63,013,060
Ensembl chr15:62,543,375...63,012,975 		JBrowse link
G Diras2 DIRAS family GTPase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DIRAS2 mRNA CTD PMID:37567420 NCBI chr17:12,730,040...12,761,511
Ensembl chr17:12,725,149...12,761,663 		JBrowse link
G Disc1 DISC1 scaffold protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of DISC1 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DISC1 mRNA CTD PMID:37567420 NCBI chr19:53,014,201...53,223,617
Ensembl chr19:53,014,616...53,219,778 		JBrowse link
G Disp2 dispatched RND transporter family member 2 increases expression
multiple interactions		 ISO Glucose results in increased expression of DISP2 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of DISP2 mRNA]		 CTD PMID:33448797 NCBI chr 3:105,762,303...105,777,826
Ensembl chr 3:105,762,305...105,777,800 		JBrowse link
G Dkk1 dickkopf WNT signaling pathway inhibitor 1 multiple interactions ISO DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in decreased expression of CDH1 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of ACTA2 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of COL1A1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of CTNNB1 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; DKK1 protein inhibits the reaction [Glucose results in increased expression of LEF1 mRNA] CTD PMID:29163160 NCBI chr 1:228,381,521...228,385,202
Ensembl chr 1:228,381,521...228,385,202 		JBrowse link
G Dlk1 delta like non-canonical Notch ligand 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of DLK1 mRNA CTD PMID:37567420 NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522 		JBrowse link
G Dmtn dematin actin binding protein increases methylation
multiple interactions
decreases expression		 ISO Glucose results in increased methylation of DMTN gene
fucoxanthin inhibits the reaction [Glucose results in decreased expression of DMTN mRNA]		 CTD PMID:33448797 NCBI chr15:45,677,974...45,702,261
Ensembl chr15:45,677,977...45,705,601 		JBrowse link
G Dnajb11 DnaJ heat shock protein family (Hsp40) member B11 decreases expression ISO Glucose results in decreased expression of DNAJB11 mRNA CTD PMID:17178593 NCBI chr11:78,151,750...78,168,259
Ensembl chr11:78,150,429...78,180,407 		JBrowse link
G Dnajc3 DnaJ heat shock protein family (Hsp40) member C3 decreases expression ISO Glucose results in decreased expression of DNAJC3 mRNA CTD PMID:17178593 NCBI chr15:96,025,605...96,068,585
Ensembl chr15:96,025,624...96,065,181 		JBrowse link
G Dnase1l3 deoxyribonuclease 1L3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of DNASE1L3 mRNA CTD PMID:37567420 NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317 		JBrowse link
G Dnm1l dynamin 1-like increases expression
multiple interactions		 EXP
ISO		 Glucose results in increased expression of DNM1L protein
[Glucose co-treated with Deferoxamine] results in increased expression of DNM1L mRNA; diallyl trisulfide inhibits the reaction [Glucose results in increased expression of DNM1L protein]; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of DNM1L mRNA]
[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of DNM1L protein; cinnamic acid inhibits the reaction [Glucose results in increased expression of DNM1L protein]; Metformin inhibits the reaction [Glucose results in increased expression of DNM1L protein]; qishen yiqi inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased phosphorylation of DNM1L protein]		 CTD PMID:27684054 PMID:30144576 PMID:31115753 PMID:33962019 PMID:36806343 NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482 		JBrowse link
G Dnmt1 DNA methyltransferase 1 increases expression ISO Glucose results in increased expression of DNMT1 mRNA CTD PMID:29854080 NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659 		JBrowse link
G Dok7 docking protein 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of DOK7 mRNA CTD PMID:37567420 NCBI chr14:75,665,444...75,699,413
Ensembl chr14:75,666,744...75,699,386 		JBrowse link
G Dpep2 dipeptidase 2 increases expression ISO Glucose results in increased expression of DPEP2 mRNA CTD PMID:31525975 NCBI chr19:33,883,557...33,896,487
Ensembl chr19:33,885,478...33,891,954 		JBrowse link
G Dpp6 dipeptidyl peptidase like 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of DPP6 mRNA CTD PMID:37567420 NCBI chr 4:7,589,386...8,508,666
Ensembl chr 4:7,591,009...8,508,532 		JBrowse link
G Dscaml1 DS cell adhesion molecule-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of DSCAML1 mRNA CTD PMID:37567420 NCBI chr 8:45,740,298...46,057,322
Ensembl chr 8:45,740,298...46,057,320 		JBrowse link
G Duox1 dual oxidase 1 decreases expression ISO Glucose results in decreased expression of DUOX1 mRNA CTD PMID:32942007 NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563 		JBrowse link
G Duox2 dual oxidase 2 decreases expression ISO Glucose results in decreased expression of DUOX2 mRNA CTD PMID:32942007 NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902 		JBrowse link
G Dusp1 dual specificity phosphatase 1 increases expression ISO Glucose results in increased expression of DUSP1 mRNA CTD PMID:17178593 PMID:32942007 NCBI chr10:16,680,478...16,683,275 JBrowse link
G Dusp13b dual specificity phosphatase 13B decreases expression
multiple interactions		 ISO Glucose results in decreased expression of DUSP13B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of DUSP13B mRNA]		 CTD PMID:31525975 PMID:33448797 NCBI chr15:2,567,432...2,575,105
Ensembl chr15:2,533,547...2,575,539 		JBrowse link
G Dusp2 dual specificity phosphatase 2 increases expression ISO Glucose results in increased expression of DUSP2 mRNA CTD PMID:17178593 NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:114,556,325...114,558,499 		JBrowse link
G Dusp5 dual specificity phosphatase 5 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of DUSP5 mRNA CTD PMID:37567420 NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818 		JBrowse link
G Dusp6 dual specificity phosphatase 6 increases expression ISO Glucose results in increased expression of DUSP6 mRNA CTD PMID:17178593 NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185 		JBrowse link
G Ebln1 endogenous Bornavirus like nucleoprotein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of IGKV8-24 mRNA CTD PMID:37567420 NCBI chr10:78,938,645...78,940,651 JBrowse link
G Edaradd EDAR associated via death domain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of EDARADD mRNA CTD PMID:37567420 NCBI chr17:85,866,629...85,910,612
Ensembl chr17:85,656,905...85,910,447 		JBrowse link
G Edem1 ER degradation enhancing alpha-mannosidase like protein 1 decreases expression ISO Glucose results in decreased expression of EDEM1 mRNA CTD PMID:17178593 NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717 		JBrowse link
G Edn1 endothelin 1 multiple interactions
increases expression
decreases expression		 ISO
EXP		 carvedilol inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; carvedilol inhibits the reaction [Glucose results in increased expression of EDN1 protein]; CAT protein inhibits the reaction [Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]]; CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPA protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; CEBPB protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPB protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; CEBPD protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein]; CEBPD protein affects the reaction [Glucose results in increased expression of EDN1 mRNA]; diphenyleneiodonium inhibits the reaction [Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]]; Glucose promotes the reaction [CEBPA protein binds to EDN1 promoter]; Glucose promotes the reaction [CEBPB protein binds to EDN1 promoter]; Glucose promotes the reaction [CEBPD protein binds to EDN1 promoter]; Glucose promotes the reaction [EDN1 protein results in increased chemical synthesis of Inositol 1,4,5-Trisphosphate]; pyrazolanthrone inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; SB 203580 inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]; U 0126 inhibits the reaction [Glucose results in increased expression of EDN1 mRNA]
Glucose affects the reaction [EDN1 protein affects the abundance of and affects the localization of Calcium]; HIF1A protein affects the reaction [Glucose results in increased expression of EDN1 protein]; MIR217 mRNA affects the reaction [Glucose results in increased expression of EDN1 protein]; resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 protein]; SIRT1 protein affects the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of EDN1 protein]]
Glucose results in increased expression of EDN1 mRNA; Glucose results in increased expression of EDN1 protein
Glucose results in decreased expression of EDN1 mRNA		 CTD PMID:12821678 PMID:16428915 PMID:20691780 PMID:20960276 PMID:24376792 More... NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885 		JBrowse link
G Edn3 endothelin 3 multiple interactions EXP EDN3 protein inhibits the reaction [SLC5A2 protein results in increased uptake of Glucose] CTD PMID:15127950 NCBI chr 3:163,562,307...163,586,636
Ensembl chr 3:163,562,520...163,585,093 		JBrowse link
G Ednra endothelin receptor type A increases expression ISO Glucose results in increased expression of EDNRA mRNA CTD PMID:31655124 NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049 		JBrowse link
G Eef1a1 eukaryotic translation elongation factor 1 alpha 1 multiple interactions EXP EEF1A1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 8:79,341,554...79,344,784
Ensembl chr 8:79,341,557...79,344,839 		JBrowse link
G Eef2 eukaryotic translation elongation factor 2 multiple interactions
decreases phosphorylation		 ISO resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of EEF2 protein] CTD PMID:19765649 NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183 		JBrowse link
G Eef2k eukaryotic elongation factor-2 kinase multiple interactions
increases phosphorylation		 ISO resveratrol inhibits the reaction [Glucose results in increased phosphorylation of EEF2K protein] CTD PMID:19765649 NCBI chr 1:175,393,119...175,456,756
Ensembl chr 1:175,393,154...175,455,164 		JBrowse link
G Efhc1 EF-hand domain containing 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of EFHC1 mRNA CTD PMID:37567420 NCBI chr 9:23,375,815...23,414,283
Ensembl chr 9:23,375,840...23,414,283 		JBrowse link
G Egf epidermal growth factor multiple interactions ISO EGF protein inhibits the reaction [Glucose results in decreased expression of CAV1 mRNA]; EGF protein promotes the reaction [Glucose results in increased expression of TGFA mRNA]; Glucose promotes the reaction [EGF protein results in increased expression of TGFA mRNA] CTD PMID:8638660 PMID:19816600 NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO [Palmitic Acid co-treated with Glucose] results in increased phosphorylation of EGFR protein; albiflorin inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of EGFR protein]; zhenwu decoction inhibits the reaction [[Palmitic Acid co-treated with Glucose] results in increased phosphorylation of EGFR protein] CTD PMID:37523837 NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382 		JBrowse link
G Egr1 early growth response 1 multiple interactions
increases expression		 ISO Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]; Valsartan inhibits the reaction [Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]]
Glucose results in increased expression of EGR1 mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of EGR1 mRNA		 CTD PMID:17178593 PMID:19225232 PMID:37567420 NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766 		JBrowse link
G Egr2 early growth response 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of EGR2 mRNA CTD PMID:37567420 NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562 		JBrowse link
G Ehd3 EH-domain containing 3 multiple interactions EXP EHD3 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 NCBI chr 6:21,640,861...21,665,601
Ensembl chr 6:21,639,290...21,665,236 		JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EHHADH mRNA CTD PMID:37567420 NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188 		JBrowse link
G Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 2 multiple interactions
increases phosphorylation		 ISO acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK2 protein]; Glucose promotes the reaction [EIF2AK2 protein results in increased activity of MAPK14 protein] CTD PMID:18973755 NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions
increases phosphorylation		 ISO
EXP		 4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of EIF2AK3 protein]
Glucose results in increased phosphorylation of EIF2AK3 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of EIF2AK3 protein]		 CTD PMID:31022492 PMID:34801538 NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha multiple interactions
increases phosphorylation		 ISO
EXP		 acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Glucose results in increased phosphorylation of EIF2S1 protein]
Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of EIF2S1 protein]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of EIF2S1 protein]
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of EIF2S1 protein]; salubrinal inhibits the reaction [4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of EIF2S1 protein]]		 CTD PMID:18973755 PMID:31022492 PMID:34801538 NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225 		JBrowse link
G Eif4a1 eukaryotic translation initiation factor 4A1 increases degradation ISO Glucose deficiency results in increased degradation of EIF4A1 protein CTD PMID:30821613 NCBI chr10:54,384,345...54,389,855
Ensembl chr10:54,384,347...54,389,858 		JBrowse link
G Eif4e eukaryotic translation initiation factor 4E increases phosphorylation
multiple interactions		 ISO Glucose results in increased phosphorylation of EIF4E protein
Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]; resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]]; resveratrol inhibits the reaction [Glucose results in increased phosphorylation of EIF4E protein]		 CTD PMID:19765649 NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683 		JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions EXP
ISO		 resveratrol inhibits the reaction [Glucose results in increased phosphorylation of EIF4EBP1 protein]
[AKT1 protein mutant form results in increased susceptibility to Glucose deficiency] which results in increased phosphorylation of EIF4EBP1 protein		 CTD PMID:15806154 PMID:20332614 NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984 		JBrowse link
G Eif4g1 eukaryotic translation initiation factor 4 gamma 1 multiple interactions ISO Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]; resveratrol inhibits the reaction [Glucose promotes the reaction [EIF4E protein binds to EIF4G1 protein]] CTD PMID:19765649 NCBI chr11:80,221,919...80,241,958
Ensembl chr11:80,221,919...80,241,941 		JBrowse link
G Eif4h eukaryotic translation initiation factor 4H increases degradation ISO Glucose deficiency results in increased degradation of EIF4H protein CTD PMID:30821613 NCBI chr12:22,083,155...22,099,876
Ensembl chr12:22,082,835...22,099,876 		JBrowse link
G Elapor1 endosome-lysosome associated apoptosis and autophagy regulator 1 increases expression
multiple interactions		 ISO Glucose results in increased expression of ELAPOR1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of ELAPOR1 mRNA]		 CTD PMID:31525975 PMID:33448797 NCBI chr 2:196,089,199...196,169,055
Ensembl chr 2:196,091,646...196,168,716 		JBrowse link
G Elk3 ETS transcription factor ELK3 increases expression ISO Glucose results in increased expression of ELK3 mRNA CTD PMID:17178593 NCBI chr 7:27,768,582...27,831,088
Ensembl chr 7:27,768,599...27,804,084 		JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 increases expression
multiple interactions		 ISO
EXP		 Glucose results in increased expression of ELOVL6 mRNA
(R)-2-(3-((benzoxazol-2-yl-d4 (3-(4-methoxyphenoxy-d7)propyl)amino)methyl)phenoxy) butanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; 2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxo-1-propenyl)phenoxyl)-2-methylpropanoic acid affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA; lanifibranor affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; Rosiglitazone affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]; saroglitazar affects the reaction [[osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] affects the expression of ELOVL6 mRNA]		 CTD PMID:15066988 PMID:16790840 PMID:32613381 NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186 		JBrowse link
G Emc1 ER membrane protein complex subunit 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of EMC1 mRNA CTD PMID:37567420 NCBI chr 5:151,608,557...151,633,888
Ensembl chr 5:151,608,568...151,633,888 		JBrowse link
G Endog endonuclease G multiple interactions
affects localization		 ISO
EXP		 [Glucose deficiency co-treated with Acetylcysteine] affects the localization of ENDOG protein; [Glucose deficiency co-treated with CAT] affects the localization of ENDOG protein; [Glucose deficiency co-treated with Tetradecanoylphorbol Acetate] affects the localization of ENDOG protein
Glucose affects the localization of ENDOG protein		 CTD PMID:17309078 PMID:23192364 NCBI chr 3:13,449,113...13,451,715
Ensembl chr 3:13,449,086...13,451,932 		JBrowse link
G Enkur enkurin, TRPC channel interacting protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ENKUR mRNA CTD PMID:37567420 NCBI chr17:83,690,105...83,714,756
Ensembl chr17:83,690,797...83,714,408 		JBrowse link
G Eno1 enolase 1 decreases secretion ISO Glucose deficiency results in decreased secretion of ENO1 protein CTD PMID:24802182 NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
Ensembl chr 3:160,719,951...160,731,336 		JBrowse link
G Eno2 enolase 2 increases secretion ISO Glucose deficiency results in increased secretion of ENO2 protein CTD PMID:24802182 NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980 		JBrowse link
G Entpd1 ectonucleoside triphosphate diphosphohydrolase 1 increases expression ISO Glucose results in increased expression of ENTPD1 mRNA CTD PMID:31525975 NCBI chr 1:239,425,515...239,552,323
Ensembl chr 1:239,425,430...239,552,317 		JBrowse link
G Entpd4 ectonucleoside triphosphate diphosphohydrolase 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ENTPD4 mRNA CTD PMID:37567420 NCBI chr15:44,630,878...44,658,654
Ensembl chr15:44,630,873...44,658,706 		JBrowse link
G Ep300 E1A binding protein p300 multiple interactions
increases expression		 ISO [cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] promotes the reaction [HIF1A protein binds to EP300 protein]] CTD PMID:22228707 PMID:25192544 PMID:26045780 NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088
Ensembl chr 7:113,106,247...113,136,088 		JBrowse link
G Epb42 erythrocyte membrane protein band 4.2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPB42 mRNA CTD PMID:37567420 NCBI chr 3:107,979,709...107,997,932
Ensembl chr 3:107,979,713...107,997,932 		JBrowse link
G Ephx4 epoxide hydrolase 4 decreases expression ISO Glucose results in decreased expression of EPHX4 mRNA CTD PMID:31525975 NCBI chr14:2,343,376...2,372,680
Ensembl chr14:2,340,248...2,373,022 		JBrowse link
G Epo erythropoietin multiple interactions ISO [EPO protein co-treated with Glucose] results in increased expression of RUNX2 mRNA; [EPO protein co-treated with Glucose] results in increased expression of RUNX2 protein; [EPO protein co-treated with Glucose] results in increased expression of SP7 mRNA; [EPO protein co-treated with Glucose] results in increased expression of SP7 protein CTD PMID:30894315 NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946 		JBrowse link
G Epop elongin BC and polycomb repressive complex 2 associated protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of EPOP mRNA CTD PMID:37567420 NCBI chr10:82,624,392...82,625,912
Ensembl chr10:82,624,392...82,625,912 		JBrowse link
G Eppk1 epiplakin 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of EPPK1 mRNA CTD PMID:37567420 NCBI chr 7:107,816,919...107,842,946
Ensembl chr 7:107,817,693...107,831,159 		JBrowse link
G Epsti1 epithelial stromal interaction 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of EPSTI1 mRNA CTD PMID:37567420 NCBI chr15:53,283,964...53,382,192
Ensembl chr15:53,284,216...53,382,191 		JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 multiple interactions ISO [Glucose deficiency co-treated with Quercetin] results in increased ubiquitination of ERBB2 protein; Glucose deficiency inhibits the reaction [Quercetin promotes the reaction [ERBB2 protein binds to HSP90AA1 protein]] CTD PMID:18655187 NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078 		JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 multiple interactions EXP [NRG1 protein binds to ERBB3 protein] which results in increased transport of Glucose CTD PMID:14711829 NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525 		JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit multiple interactions
increases expression		 ISO 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC1 protein]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC1 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 protein]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC1 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC1 protein]
Glucose results in increased expression of ERCC1 mRNA; Glucose results in increased expression of ERCC1 protein		 CTD PMID:22228707 NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963 		JBrowse link
G Ercc4 ERCC excision repair 4, endonuclease catalytic subunit increases expression
multiple interactions		 ISO Glucose results in increased expression of ERCC4 mRNA; Glucose results in increased expression of ERCC4 protein
3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; 3-aminobenzamide inhibits the reaction [Glucose results in increased expression of ERCC4 protein]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of ERCC4 protein]; ERCC4 protein affects the reaction [Glucose results in increased expression of EP300 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of ERCC1 protein]; ERCC4 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of PARP1 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 mRNA]; trichostatin A inhibits the reaction [Glucose results in increased expression of ERCC4 protein]		 CTD PMID:22228707 NCBI chr10:2,416,259...2,448,364
Ensembl chr10:2,419,038...2,448,369
Ensembl chr10:2,419,038...2,448,369 		JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 increases phosphorylation
multiple interactions		 ISO
EXP		 Glucose deficiency results in increased phosphorylation of ERN1 protein
Glucose results in increased phosphorylation of ERN1 protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased phosphorylation of ERN1 protein]; Metformin inhibits the reaction [Glucose results in increased phosphorylation of ERN1 protein]
4-Quinolones analog inhibits the reaction [Glucose deficiency results in increased phosphorylation of ERN1 protein]; [Glucose co-treated with TGFB1 protein] results in increased phosphorylation of ERN1 protein; aucubin inhibits the reaction [[Glucose co-treated with TGFB1 protein] results in increased phosphorylation of ERN1 protein]		 CTD PMID:31022492 PMID:34801538 PMID:35961541 NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029 		JBrowse link
G Ern2 endoplasmic reticulum to nucleus signaling 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of ERN2 mRNA CTD PMID:37567420 NCBI chr 1:176,726,454...176,743,289
Ensembl chr 1:176,726,454...176,743,289 		JBrowse link
G Ero1a endoplasmic reticulum oxidoreductase 1 alpha decreases expression
increases expression
multiple interactions		 ISO
EXP		 Glucose results in decreased expression of ERO1A mRNA
Glucose results in increased expression of ERO1A protein
Chlorogenic Acid inhibits the reaction [Glucose results in increased expression of ERO1A protein]; Metformin inhibits the reaction [Glucose results in increased expression of ERO1A protein]		 CTD PMID:17178593 PMID:34801538 NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478 		JBrowse link
G Esr1 estrogen receptor 1 increases expression
decreases expression
multiple interactions
increases phosphorylation
increases abundance		 ISO
EXP		 Glucose results in increased expression of ESR1 mRNA
Glucose results in decreased expression of ESR1 mRNA
[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ESR1 mRNA; ESR1 protein promotes the reaction [[Resveratrol results in increased localization of SLC2A4 protein] which results in increased uptake of Glucose]; tetrahydropalmatine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of ESR1 mRNA]
Glucose results in increased phosphorylation of ESR1 protein
ESR1 protein results in increased abundance of Glucose
Endosulfan promotes the reaction [ESR1 protein results in increased abundance of Glucose]		 CTD PMID:16621514 PMID:18426865 PMID:23690508 PMID:31520823 PMID:37606869 NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002 		JBrowse link
G Esr2 estrogen receptor 2 increases expression
decreases expression		 ISO Glucose results in increased expression of ESR2 mRNA
Glucose results in decreased expression of ESR2 mRNA		 CTD PMID:16621514 NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919 		JBrowse link
G Esrp1 epithelial splicing regulatory protein 1 increases expression
multiple interactions		 ISO Glucose results in increased expression of ESRP1 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of ESRP1 mRNA]		 CTD PMID:33448797 NCBI chr 5:24,427,611...24,482,157
Ensembl chr 5:24,428,717...24,482,062 		JBrowse link
G Esrra estrogen related receptor, alpha decreases expression
multiple interactions		 ISO Glucose results in decreased expression of ESRRA protein
resveratrol inhibits the reaction [Glucose results in decreased expression of ESRRA protein]		 CTD PMID:23090186 NCBI chr 1:204,104,100...204,114,182
Ensembl chr 1:204,104,101...204,114,268 		JBrowse link
G Ezr ezrin multiple interactions
decreases expression		 ISO Eucalyptol inhibits the reaction [Glucose results in decreased expression of EZR protein] CTD PMID:31483951 NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505 		JBrowse link
G F13a1 coagulation factor XIII A1 chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of F13A1 mRNA CTD PMID:37567420 NCBI chr17:27,815,723...27,992,494
Ensembl chr17:27,815,702...27,992,700 		JBrowse link
G F2r coagulation factor II (thrombin) receptor decreases expression ISO Glucose results in decreased expression of F2R mRNA CTD PMID:31655124 NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870 		JBrowse link
G F3 coagulation factor III, tissue factor multiple interactions
increases expression		 ISO Fluorometholone inhibits the reaction [Glucose results in increased expression of F3 mRNA]; Fluorometholone inhibits the reaction [Glucose results in increased expression of F3 protein]
Glucose results in increased expression of F3 mRNA; Glucose results in increased expression of F3 protein		 CTD PMID:35264022 NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668 		JBrowse link
G F7 coagulation factor VII multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of F7 mRNA CTD PMID:37567420 NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610 		JBrowse link
G Fabp1 fatty acid binding protein 1 increases expression ISO Glucose results in increased expression of FABP1 mRNA CTD PMID:36156098 NCBI chr 4:103,191,015...103,194,791
Ensembl chr 4:103,191,006...103,194,788 		JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions
increases expression		 ISO
EXP		 [Glucose deficiency co-treated with ALB protein] results in decreased expression of FABP4 mRNA; [Glucose deficiency co-treated with Clofibrate co-treated with Oleic Acid] results in increased expression of FABP4 mRNA; [Glucose deficiency co-treated with Clofibrate] results in increased expression of FABP4 mRNA; [Glucose deficiency co-treated with Oleic Acid] results in increased expression of FABP4 mRNA
[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA; avobenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; dioxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]; oxybenzone promotes the reaction [[Glucose co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]
Glucose results in increased expression of FABP4 mRNA		 CTD PMID:3299706 PMID:8536680 PMID:32407875 NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578 		JBrowse link
G Fam163a family with sequence similarity 163, member A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of FAM163A mRNA CTD PMID:37567420 NCBI chr13:68,262,867...68,341,323
Ensembl chr13:68,262,872...68,341,049 		JBrowse link
G Fam163b family with sequence similarity 163, member B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAM163B mRNA CTD PMID:37567420 NCBI chr 3:10,437,383...10,466,458
Ensembl chr 3:10,437,383...10,466,458 		JBrowse link
G Fam167a family with sequence similarity 167, member A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAM167A mRNA CTD PMID:37567420 NCBI chr15:37,685,221...37,715,472
Ensembl chr15:37,700,919...37,715,469 		JBrowse link
G Fam178b family with sequence similarity 178, member B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of FAM178B mRNA CTD PMID:37567420 NCBI chr 9:38,805,864...38,913,681
Ensembl chr 9:38,805,864...38,913,672 		JBrowse link
G Fam78b family with sequence similarity 78, member B decreases expression
multiple interactions		 ISO Glucose results in decreased expression of FAM78B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of FAM78B mRNA]		 CTD PMID:33448797 NCBI chr13:79,162,393...79,250,958
Ensembl chr13:79,162,228...79,250,500 		JBrowse link
G Fam83c family with sequence similarity 83, member C multiple interactions
increases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in increased expression of FAM83C mRNA] CTD PMID:33448797 NCBI chr 3:144,333,736...144,339,758
Ensembl chr 3:144,332,982...144,339,802 		JBrowse link
G Fam98c family with sequence similarity 98, member C decreases expression
multiple interactions		 ISO Glucose results in decreased expression of FAM98C mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of FAM98C mRNA]		 CTD PMID:33448797 NCBI chr 1:84,452,806...84,456,414
Ensembl chr 1:84,452,814...84,456,385 		JBrowse link
G Fas Fas cell surface death receptor increases expression
decreases expression
multiple interactions		 ISO Glucose results in increased expression of FAS mRNA; Glucose results in increased expression of FAS protein
Glucose results in decreased expression of FAS mRNA
dorsomorphin inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of FAS mRNA]]; dorsomorphin inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of FAS protein]]; platycodin D inhibits the reaction [Glucose results in increased expression of FAS mRNA]; platycodin D inhibits the reaction [Glucose results in increased expression of FAS protein]; STO 609 inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of FAS mRNA]]		 CTD PMID:23319015 PMID:31655124 NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591 		JBrowse link
G Faslg Fas ligand increases expression
multiple interactions		 ISO Glucose results in increased expression of FASLG mRNA
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FASL mRNA		 CTD PMID:31655124 PMID:37567420 NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215 		JBrowse link
G Fasn fatty acid synthase increases expression
multiple interactions		 ISO
EXP		 Glucose results in increased expression of FASN mRNA
Allopurinol inhibits the reaction [Glucose results in increased expression of FASN protein]; Glucose promotes the reaction [SREBF1 protein binds to FASN promoter]; Quercetin inhibits the reaction [Glucose results in increased expression of FASN protein]
[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides; [INS protein co-treated with Glucose] results in increased expression of FASN mRNA; [Resveratrol results in increased activity of SIRT1 protein] inhibits the reaction [[Glucose results in increased expression of FASN protein] which results in increased abundance of Triglycerides]; Allopurinol inhibits the reaction [Glucose results in increased expression of FASN protein]; PRKAA2 protein promotes the reaction [SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]]; Quercetin inhibits the reaction [Glucose results in increased expression of FASN protein]; SIRT1 protein inhibits the reaction [Glucose results in increased expression of FASN protein]; SRT1720 inhibits the reaction [[INS protein co-treated with Glucose] results in increased expression of FASN mRNA]		 CTD PMID:15066988 PMID:18482975 PMID:19724016 PMID:22031849 PMID:23647015 NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261 		JBrowse link
G Fat3 FAT atypical cadherin 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of FAT3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAT3 mRNA CTD PMID:37567420 NCBI chr 8:12,691,470...13,274,336
Ensembl chr 8:12,694,019...13,273,135 		JBrowse link
G Faxc failed axon connections homolog, metaxin like GST domain containing multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FAXC mRNA CTD PMID:37567420 NCBI chr 5:35,480,137...35,539,741
Ensembl chr 5:35,480,402...35,544,446 		JBrowse link
G Fbp2 fructose-bisphosphatase 2 multiple interactions
decreases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of FBP2 mRNA] CTD PMID:33448797 NCBI chr17:2,236,088...2,253,702
Ensembl chr17:2,236,336...2,253,698 		JBrowse link
G Fbxl13 F-box and leucine-rich repeat protein 13 increases expression ISO Glucose results in increased expression of FBXL13 mRNA CTD PMID:31525975 NCBI chr 4:13,414,880...13,607,079
Ensembl chr 4:13,414,926...13,641,494 		JBrowse link
G Fbxo32 F-box protein 32 multiple interactions
increases expression		 ISO FBXO32 protein affects the reaction [Glucose results in decreased expression of KCNN2 protein]
Glucose results in increased expression of FBXO32 protein		 CTD PMID:30635400 NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436 		JBrowse link
G Fbxo47 F-box protein 47 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FBXO47 mRNA CTD PMID:37567420 NCBI chr10:82,849,514...82,880,337
Ensembl chr10:82,849,730...82,879,538 		JBrowse link
G Fbxo48 F-box protein 48 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of FBXO48 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FBXO48 mRNA CTD PMID:37567420 NCBI chr14:91,380,857...91,382,314
Ensembl chr14:91,380,857...91,382,314 		JBrowse link
G Fbxw12 F-box and WD repeat domain containing 12 increases expression ISO Glucose results in increased expression of FBXW12 CTD PMID:36073553 NCBI chr 8:109,782,315...109,802,086
Ensembl chr 8:109,786,815...109,801,813 		JBrowse link
G Fcer1g Fc epsilon receptor Ig decreases expression ISO Glucose results in decreased expression of FCER1G mRNA CTD PMID:31525975 NCBI chr13:83,649,447...83,654,248
Ensembl chr13:83,649,449...83,671,443 		JBrowse link
G Fcgr3a Fc gamma receptor 3A multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of FCGR4 mRNA CTD PMID:37567420 NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921 		JBrowse link
G Fcho1 FCH and mu domain containing endocytic adaptor 1 multiple interactions
decreases expression		 ISO fucoxanthin inhibits the reaction [Glucose results in decreased expression of FCHO1 mRNA] CTD PMID:33448797 NCBI chr16:18,413,452...18,430,795
Ensembl chr16:18,413,363...18,435,104 		JBrowse link
G Fcrlb Fc receptor-like B multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FCRLB mRNA CTD PMID:37567420 NCBI chr13:83,148,685...83,157,157
Ensembl chr13:83,149,751...83,155,957 		JBrowse link
G Fen1 flap structure-specific endonuclease 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in decreased expression of FEN1 mRNA CTD PMID:37567420 NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003 		JBrowse link
G Fendrr FOXF1 adjacent non-coding developmental regulatory RNA multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of FENDRR mRNA CTD PMID:37567420 NCBI chr19:49,127,225...49,152,780
Ensembl chr19:49,121,214...49,153,240 		JBrowse link
G Ffar1 free fatty acid receptor 1 decreases expression
multiple interactions		 EXP
ISO		 Glucose results in decreased expression of FFAR1 mRNA
[FFAR1 protein affects the susceptibility to Dietary Fats] affects the reaction [Glucose results in increased secretion of INS1 protein]; FFAR1 protein affects the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of INS1 protein]]		 CTD PMID:24349266 PMID:37217659 NCBI chr 1:86,111,368...86,112,272
Ensembl chr 1:86,111,368...86,112,272 		JBrowse link
G Ffar3 free fatty acid receptor 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of FFAR3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FFAR3 mRNA CTD PMID:37567420 NCBI chr 1:86,105,388...86,106,728
Ensembl chr 1:86,104,920...86,106,849 		JBrowse link
G Fgf1 fibroblast growth factor 1 increases expression
multiple interactions
decreases expression		 ISO Glucose results in increased expression of FGF1 mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased expression of FGF1 mRNA]		 CTD PMID:31655124 PMID:33448797 NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357 		JBrowse link
G Fgf2 fibroblast growth factor 2 increases expression
multiple interactions
decreases expression		 EXP
ISO		 Glucose results in increased expression of FGF2 mRNA; Glucose results in increased expression of FGF2 protein
Glucosamine promotes the reaction [Glucose results in increased expression of FGF2 mRNA]
Glucose results in decreased expression of FGF2 mRNA		 CTD PMID:1518840 PMID:19759273 PMID:31655124 NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221 		JBrowse link
G Fgf21 fibroblast growth factor 21 affects uptake
increases secretion
multiple interactions
increases expression		 ISO FGF21 protein affects the uptake of Glucose
Glucose results in increased secretion of FGF21 protein
indolo(3,2-b)carbazole inhibits the reaction [Glucose deficiency results in increased expression of FGF21 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Glucose deficiency results in increased expression of FGF21 mRNA]
indolo(3,2-b)carbazole inhibits the reaction [Glucose results in increased expression of FGF21 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Glucose results in increased expression of FGF21 mRNA]		 CTD PMID:15902306 PMID:27226639 PMID:28123933 NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:96,083,441...96,090,454 		JBrowse link
G Fgf7 fibroblast growth factor 7 affects transport ISO FGF7 protein affects the transport of Glucose CTD PMID:12757114 NCBI chr 3:113,280,448...113,333,279
Ensembl chr 3:113,281,283...113,332,929 		JBrowse link
G Fgg fibrinogen gamma chain multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FGG mRNA CTD PMID:37567420 NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322 		JBrowse link
G Fgl2 fibrinogen-like 2 increases expression
multiple interactions		 ISO Glucose results in increased expression of FGL2 mRNA
fucoxanthin inhibits the reaction [Glucose results in increased expression of FGL2 mRNA]		 CTD PMID:33448797 NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207 		JBrowse link
G Fhad1 forkhead associated phosphopeptide binding domain 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of FHAD1 mRNA CTD PMID:37567420 NCBI chr 5:154,191,593...154,310,442
Ensembl chr 5:154,191,745...154,310,354 		JBrowse link
G Fis1 fission, mitochondrial 1 increases expression
multiple interactions		 EXP
ISO		 Glucose results in increased expression of FIS1 protein
[Glucose co-treated with Deferoxamine] results in increased expression of FIS1 mRNA; Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of FIS1 mRNA]
cinnamic acid inhibits the reaction [Glucose results in increased expression of FIS1 protein]; Metformin inhibits the reaction [Glucose results in increased expression of FIS1 protein]		 CTD PMID:27684054 PMID:30144576 PMID:33962019 NCBI chr12:19,708,560...19,723,392
Ensembl chr12:19,708,558...19,723,377 		JBrowse link
G Flg filaggrin multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of FLG mRNA CTD PMID:37567420 NCBI chr 2:178,884,793...178,912,986 JBrowse link
G Flg2 filaggrin 2 decreases methylation
decreases expression		 ISO Glucose results in decreased methylation of FLG2 promoter
Glucose results in decreased expression of FLG2 mRNA		 CTD PMID:31525975 NCBI chr 2:178,789,792...178,802,232 JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 decreases expression
multiple interactions		 ISO Glucose results in decreased expression of FLT1 mRNA; Glucose results in decreased expression of FLT1 protein
[Glucose co-treated with ICG 001] results in decreased expression of FLT1 protein; Panax notoginseng extract inhibits the reaction [[Glucose co-treated with ICG 001] results in decreased expression of FLT1 protein]; Panax notoginseng extract inhibits the reaction [Glucose results in decreased expression of FLT1 protein]		 CTD PMID:31655124 PMID:35385194 NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626 		JBrowse link
G Fmo3 flavin containing dimethylaniline monoxygenase 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FMO3 mRNA CTD PMID:37567420 NCBI chr13:75,309,367...75,334,915
Ensembl chr13:75,309,374...75,328,028 		JBrowse link
G Fn1 fibronectin 1 increases expression
increases secretion
multiple interactions
decreases expression
decreases secretion		 ISO
EXP		 Glucose results in increased expression of FN1 mRNA; Glucose results in increased expression of FN1 protein
Glucose results in increased secretion of FN1 protein
3-aminobenzamide inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [Glucose results in increased expression of FN1 protein]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Glucose results in increased secretion of FN1 protein]; [Glucose results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased secretion of FN1 protein; acetovanillone inhibits the reaction [Glucose results in increased secretion of FN1 protein]; AKT activator SC79 inhibits the reaction [FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]]; alpha-Tocopherol inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]; Bosentan inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; Bosentan inhibits the reaction [Glucose results in increased expression of FN1 protein]; BQ 788 inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; calphostin C inhibits the reaction [Glucose results in increased secretion of FN1 protein]; chelerythrine inhibits the reaction [Glucose results in increased expression of FN1 protein]; Curcumin inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; Curcumin inhibits the reaction [Glucose results in increased expression of FN1 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased secretion of FN1 protein]; DKK1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC1 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; ERCC4 protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; gingerol inhibits the reaction [Glucose results in increased secretion of FN1 protein]; Glucose results in increased expression of and results in increased secretion of FN1 protein; Indomethacin inhibits the reaction [Glucose results in increased secretion of FN1 protein]; MAPK14 protein promotes the reaction [Glucose results in increased secretion of FN1 protein]; MIR142 affects the reaction [TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of FN1 protein]]; MIR142 inhibits the reaction [Glucose results in increased expression of FN1 protein]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Glucose results in increased expression of FN1 protein]; Rotenone inhibits the reaction [Glucose results in increased secretion of FN1 protein]; sitaxsentan inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SN50 peptide inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SN50 peptide inhibits the reaction [Glucose results in increased expression of FN1 protein]; SOX6 protein inhibits the reaction [MIR142 inhibits the reaction [Glucose results in increased expression of FN1 protein]]; TAOK1 mRNA alternative form affects the reaction [Glucose results in increased expression of FN1 protein]; trichostatin A inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; Troglitazone inhibits the reaction [Glucose results in increased expression of FN1 mRNA]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 protein]]; Enalaprilat inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; NFE2L2 protein affects the reaction [SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]]; Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SMARCA4A protein inhibits the reaction [Glucose results in increased expression of FN1 protein]; TXNIP promotes the reaction [Glucose results in increased expression of FN1 mRNA]
Glucose results in decreased expression of FN1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; [[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein; [Glucose results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1; [JTE 013 binds to and results in decreased activity of S1PR2 protein] inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; [sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein; acetovanillone inhibits the reaction [Glucose results in increased expression of FN1 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased expression of FN1 protein]; cinnamaldehyde inhibits the reaction [Glucose results in increased expression of FN1 protein]; CYBA protein promotes the reaction [Glucose results in increased expression of FN1 protein]; diphenyleneiodonium inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; diphenyliodonium inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; farrerol inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; farrerol inhibits the reaction [Glucose results in increased expression of FN1 protein]; HIF1A protein affects the reaction [Glucose results in increased expression of FN1 protein]; LY2109761 inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; manumycin inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; MIR217 mRNA affects the reaction [Glucose results in increased expression of FN1 protein]; N,N-dimethylsphingosine inhibits the reaction [Glucose results in increased expression of FN1 protein]; NCF1 protein promotes the reaction [Glucose results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [[[[Glucose results in increased expression of CYBA protein] co-treated with [Glucose results in increased expression of NCF1 protein]] results in increased chemical synthesis of Reactive Oxygen Species] which results in increased expression of FN1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]; rhodioloside inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; SB 203580 inhibits the reaction [[sphingosine 1-phosphate co-treated with Glucose] results in increased expression of FN1 protein]; SIRT1 protein affects the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of FN1 protein]]; SPHK1 mRNA affects the reaction [Glucose results in increased expression of FN1 protein]; SPHK1 protein inhibits the reaction [Glucose results in increased expression of FN1 protein]; Superoxides affects the reaction [Glucose results in increased expression of FN1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of FN1 mRNA]; TXNIP protein affects the reaction [Glucose results in increased expression of FN1 protein]; Y 27632 inhibits the reaction [Glucose results in increased expression of FN1 protein]
Glucose deficiency results in decreased secretion of FN1 protein
Glucose results in decreased expression of FN1 mRNA		 CTD PMID:9225831 PMID:12388107 PMID:14520012 PMID:15086456 PMID:16320596 More... NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678 		JBrowse link
G Folr1 folate receptor alpha decreases expression ISO Glucose results in decreased expression of FOLR1 mRNA CTD PMID:19616087 NCBI chr 1:156,219,460...156,238,436
Ensembl chr 1:156,219,460...156,230,667 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions		 ISO
EXP		 Glucose results in increased expression of FOS mRNA
[Glucose co-treated with Lipopolysaccharides] results in increased expression of FOS protein; MIR1231 inhibits the reaction [Glucose results in increased expression of FOS protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of FOS protein]
Dactinomycin inhibits the reaction [Glucose results in increased expression of FOS mRNA]; Glucose affects the reaction [Adenosine Triphosphate results in increased expression of FOS mRNA]		 CTD PMID:10723097 PMID:11123204 PMID:11557636 PMID:17178593 PMID:18180316 More... NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036 		JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression
multiple interactions		 ISO Glucose results in increased expression of FOSL1 mRNA
Glucose promotes the reaction [AGT protein results in increased expression of FOSL1 mRNA]		 CTD PMID:17178593 PMID:19225232 NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930 		JBrowse link
G Fosl2 FOS like 2, AP-1 transcription factor subunit increases expression ISO Glucose results in increased expression of FOSL2 mRNA CTD PMID:17178593 NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034 		JBrowse link
G Foxa2 forkhead box A2 multiple interactions ISO [Metformin co-treated with Glucose] affects the localization of FOXA2 protein CTD PMID:16489446 NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326 		JBrowse link
G Foxa3 forkhead box A3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of FOXA3 mRNA CTD PMID:37567420 NCBI chr 1:78,662,067...78,672,321
Ensembl chr 1:78,662,431...78,672,155 		JBrowse link
G Foxf2 forkhead box F2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FOXF2 mRNA CTD PMID:37567420 NCBI chr17:32,835,730...32,842,547
Ensembl chr17:32,836,777...32,842,176 		JBrowse link
G Foxm1 forkhead box M1 increases expression ISO Glucose results in increased expression of FOXM1 mRNA CTD PMID:32942007 NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684 		JBrowse link
G Foxo1 forkhead box O1 increases abundance
multiple interactions
decreases response to substance		 EXP
ISO		 FOXO1 protein mutant form results in increased abundance of Glucose; FOXO1 protein results in increased abundance of Glucose
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO1 protein]]; Acetylcysteine inhibits the reaction [Glucose affects the localization of FOXO1 protein]; Calcitriol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO1 protein]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of ALPL mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of BGLAP mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 mRNA]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in decreased expression of RUNX2 protein]]; FOXO1 protein inhibits the reaction [Calcitriol inhibits the reaction [Glucose results in increased expression of BECN1 protein]]; Glucose results in decreased phosphorylation of and affects the localization of FOXO1 protein
FOXO1 protein results in decreased susceptibility to Glucose
Glucose results in increased acetylation of and results in decreased activity of FOXO1 protein; SIRT3 protein inhibits the reaction [Glucose results in increased acetylation of FOXO1 protein]
FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]; FOXO1 protein inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 mRNA]]; FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of ADIPOR1 protein]]; Glucose results in increased phosphorylation of and results in decreased activity of FOXO1 protein; INS1 protein inhibits the reaction [FOXO1 protein results in increased abundance of Glucose]; INS1 protein promotes the reaction [FOXO1 protein mutant form results in increased abundance of Glucose]; resveratrol inhibits the reaction [Glucose results in increased phosphorylation of and results in decreased activity of FOXO1 protein]; resveratrol promotes the reaction [FOXO1 protein results in increased abundance of Glucose]		 CTD PMID:15788402 PMID:23494737 PMID:24413998 PMID:33450223 NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790 		JBrowse link
G Foxo3 forkhead box O3 multiple interactions
decreases expression
increases phosphorylation
increases localization		 ISO
EXP		 [[resveratrol results in increased activity of SIRT1 protein] which results in increased phosphorylation of and results in decreased activity of FOXO3 protein] which results in decreased susceptibility to Glucose; AKT1 protein promotes the reaction [Glucose affects the phosphorylation of and affects the activity of FOXO3 protein]; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP1 protein]; FOXO3 protein promotes the reaction [Glucose results in increased cleavage of and results in increased activity of CASP3 protein]; Glucose affects the phosphorylation of and affects the activity of FOXO3 protein; resveratrol inhibits the reaction [Glucose results in increased phosphorylation of FOXO3 protein]
polyethylene glycol loxenatide inhibits the reaction [Glucose results in decreased expression of FOXO3 protein]
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Glucose affects the localization of and results in increased phosphorylation of FOXO3 protein]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO3 protein]]; 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucose affects the localization of and results in increased phosphorylation of FOXO3 protein]; Acetylcysteine inhibits the reaction [Glucose results in decreased phosphorylation of FOXO3 protein]; Acetylcysteine inhibits the reaction [Glucose results in increased phosphorylation of FOXO3 protein]; Glucose results in decreased phosphorylation of and affects the localization of FOXO3 protein; Glucose results in increased phosphorylation of and affects the localization of FOXO3 protein; Resveratrol inhibits the reaction [Glucose results in decreased phosphorylation of and affects the localization of FOXO3 protein]
Glucose results in increased localization of FOXO3 protein		 CTD PMID:20370652 PMID:23090186 PMID:23159718 PMID:25471227 PMID:37417536 NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561 		JBrowse link
G Foxp1 forkhead box P1 multiple interactions
decreases expression		 ISO AKT activator SC79 inhibits the reaction [FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of CYBB protein]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of FN1 mRNA]; FOXP1 protein inhibits the reaction [Glucose results in increased expression of NOX4 protein]; FOXP1 protein inhibits the reaction [Glucose results in increased phosphorylation of MTOR protein]
Glucose results in decreased expression of FOXP1 mRNA; Glucose results in decreased expression of FOXP1 protein		 CTD PMID:31494106 NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258 		JBrowse link
G Frk fyn-related Src family tyrosine kinase multiple interactions ISO FRK protein inhibits the reaction [Glucose results in increased secretion of INS1 protein] CTD PMID:17179392 NCBI chr20:38,265,416...38,371,038
Ensembl chr20:38,265,280...38,371,114 		JBrowse link
G Frmd3 FERM domain containing 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FRMD3 mRNA CTD PMID:37567420 NCBI chr 5:87,764,755...88,031,091
Ensembl chr 5:87,764,604...88,031,091 		JBrowse link
G Frmpd3 FERM and PDZ domain containing 3 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FRMPD3 mRNA CTD PMID:37567420 NCBI chr  X:103,964,168...104,113,864
Ensembl chr  X:104,043,194...104,111,968 		JBrowse link
G Fsbp fibrinogen silencer binding protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of FSBP mRNA CTD PMID:37567420 NCBI chr 5:25,058,003...25,064,276
Ensembl chr 5:25,032,066...25,104,616 		JBrowse link
G Fsip1 fibrous sheath interacting protein 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of FSIP1 mRNA CTD PMID:37567420 NCBI chr 3:105,074,584...105,217,180
Ensembl chr 3:105,068,543...105,217,167 		JBrowse link
G Fth1 ferritin heavy chain 1 multiple interactions
increases expression		 ISO
EXP		 FTH1 protein inhibits the reaction [Glucose results in increased abundance of Reactive Oxygen Species]
[[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Oxygen] results in increased expression of [FTH1 protein binds to FTL protein]
Glucose results in increased expression of FTH1 protein		 CTD PMID:16135072 PMID:18931039 PMID:38483099 NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424 		JBrowse link
G Ftl1 ferritin light chain 1 multiple interactions
increases expression		 EXP
ISO		 [[Oxygen deficiency co-treated with Glucose deficiency] results in increased susceptibility to Oxygen] results in increased expression of [FTH1 protein binds to FTL protein]
Glucose results in increased expression of FTL protein
Glucose results in increased expression of FTL1 protein		 CTD PMID:16135072 PMID:38483099 NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725
Ensembl chr10:95,936,387...95,939,725
Ensembl chr 2:95,936,387...95,939,725 		JBrowse link
G Fut1 fucosyltransferase 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of FUT1 mRNA CTD PMID:37567420 NCBI chr 1:96,086,934...96,090,352
Ensembl chr 1:96,086,635...96,090,616 		JBrowse link
G Fut2 fucosyltransferase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in decreased expression of FUT2 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of FUT2 mRNA CTD PMID:37567420 NCBI chr 1:96,119,549...96,139,567
Ensembl chr 1:96,119,371...96,140,360 		JBrowse link
G Fxyd5 FXYD domain-containing ion transport regulator 5 increases expression ISO Glucose results in increased expression of FXYD5 mRNA CTD PMID:17178593 NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519 		JBrowse link
G G3bp1 G3BP stress granule assembly factor 1 multiple interactions
increases uptake		 ISO Deoxyglucose inhibits the reaction [G3BP1 protein results in increased uptake of Glucose]; YWHAZ protein affects the reaction [G3BP1 protein results in increased uptake of Glucose] CTD PMID:35945655 NCBI chr10:39,586,864...39,620,268
Ensembl chr10:39,586,864...39,620,268 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 multiple interactions
decreases expression
increases activity
increases expression		 ISO
EXP		 Glucose promotes the reaction [[ARNT protein binds to G6PC1 promoter] which results in increased expression of G6PC1 mRNA]; Glucose results in increased stability of and results in increased expression of G6PC1 mRNA
Glucose results in decreased expression of G6PC1 mRNA
Glucose results in increased activity of G6PC1 protein
Glucose results in increased expression of G6PC1 mRNA
Metformin inhibits the reaction [Glucose results in increased expression of G6PC1 mRNA]; tungstate inhibits the reaction [Glucose results in increased activity of G6PC1 protein]; Vanadates inhibits the reaction [Glucose results in increased activity of G6PC1 protein]
[Glucose co-treated with S 4048] results in increased expression of G6PC1 mRNA		 CTD PMID:14988444 PMID:15767253 PMID:16920846 PMID:19576170 PMID:31974165 More... NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804 		JBrowse link
G Gabbr2 gamma-aminobutyric acid type B receptor subunit 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GABBR2 mRNA CTD PMID:37567420 NCBI chr 5:60,947,517...61,288,104
Ensembl chr 5:60,947,526...61,288,104 		JBrowse link
G Gabrp gamma-aminobutyric acid type A receptor subunit pi multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GABRP mRNA CTD PMID:37567420 NCBI chr10:18,143,031...18,169,595
Ensembl chr10:18,143,038...18,169,516 		JBrowse link
G Gabrq gamma-aminobutyric acid type A receptor subunit theta multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GABRQ mRNA CTD PMID:37567420 NCBI chr  X:150,696,161...150,712,948
Ensembl chr  X:150,696,427...150,709,919 		JBrowse link
G Gad1 glutamate decarboxylase 1 multiple interactions EXP GAD1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:25966616 NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333 		JBrowse link
G Gadd45g growth arrest and DNA-damage-inducible, gamma increases expression ISO Glucose results in increased expression of GADD45G mRNA CTD PMID:17178593 NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610 		JBrowse link
G Galnt16 polypeptide N-acetylgalactosaminyltransferase 16 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GALNT16 mRNA CTD PMID:37567420 NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705 		JBrowse link
G Galnt2 polypeptide N-acetylgalactosaminyltransferase 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GALNT2 mRNA CTD PMID:37567420 NCBI chr19:52,213,226...52,324,816
Ensembl chr19:52,213,351...52,324,813 		JBrowse link
G Galnt6 polypeptide N-acetylgalactosaminyltransferase 6 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GALNT6 mRNA CTD PMID:37567420 NCBI chr 7:131,789,836...131,828,077
Ensembl chr 7:131,789,839...131,819,661 		JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase multiple interactions
increases expression
increases ADP-ribosylation		 ISO
EXP		 SOD2 protein inhibits the reaction [[Glucose results in increased chemical synthesis of Superoxides] which results in decreased activity of GAPDH protein]; SOD2 protein inhibits the reaction [Glucose results in decreased activity of and results in increased ADP-ribosylation of GAPDH protein]
Glucose results in increased expression of GAPDH mRNA
[chloroacetaldehyde results in decreased activity of GAPDH protein] which results in decreased chemical synthesis of Glucose; UCP1 protein inhibits the reaction [[Glucose results in increased chemical synthesis of Superoxides] which results in decreased activity of GAPDH protein]; UCP1 protein inhibits the reaction [Glucose results in decreased activity of and results in increased ADP-ribosylation of GAPDH protein]
Glucose results in increased ADP-ribosylation of GAPDH protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GAPDH mRNA; PARP1 protein affects the reaction [Glucose results in increased ADP-ribosylation of GAPDH protein]		 CTD PMID:7826318 PMID:11050244 PMID:14523042 PMID:19733226 PMID:37567420 NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235 		JBrowse link
G Gask1b golgi associated kinase 1B decreases expression ISO Glucose results in decreased expression of GASK1B mRNA CTD PMID:33448797 NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477 		JBrowse link
G Gast gastrin increases secretion EXP Glucose results in increased secretion of GAST protein CTD PMID:19208342 NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496 		JBrowse link
G Gata4 GATA binding protein 4 increases metabolic processing ISO GATA4 protein results in increased metabolism of Glucose CTD PMID:34087332 NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636 		JBrowse link
G Gbp2 guanylate binding protein 2 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP2 mRNA CTD PMID:37567420 NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571 		JBrowse link
G Gbp4 guanylate binding protein 4 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP3 mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP4 mRNA CTD PMID:37567420 NCBI chr 2:231,304,910...231,318,883
Ensembl chr 2:231,305,244...231,318,879 		JBrowse link
G Gbp7 guanylate binding protein 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GBP7 mRNA CTD PMID:37567420 NCBI chr 2:231,275,521...231,297,289
Ensembl chr 2:231,275,640...231,297,278 		JBrowse link
G Gc GC, vitamin D binding protein multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of GC mRNA CTD PMID:37567420 NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567 		JBrowse link
G Gcg glucagon multiple interactions
increases secretion
increases abundance
decreases secretion		 ISO
EXP		 Glucose inhibits the reaction [[Niacin results in decreased abundance of Fatty Acids, Nonesterified] which results in increased secretion of GCG protein]
[GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; isosteviol inhibits the reaction [Palmitic Acid promotes the reaction [Glucose results in increased secretion of GCG protein]]; Palmitic Acid promotes the reaction [Glucose results in increased secretion of GCG protein]
GCG results in increased abundance of Glucose
9-phenanthrol inhibits the reaction [[GCG protein co-treated with Glucose] results in increased secretion of INS1 protein]; [GCG protein co-treated with Glucose] results in increased secretion of INS1 protein; [GCG protein modified form binds to and results in increased activity of GLP1R protein] promotes the reaction [Glucose results in increased secretion of INS1 protein]; Metformin inhibits the reaction [GCG results in increased abundance of Glucose]; Troglitazone inhibits the reaction [Glucose results in decreased secretion of GCG protein]; Zinc inhibits the reaction [Glucose results in increased secretion of GCG protein]		 CTD PMID:838844 PMID:12914525 PMID:15919803 PMID:18669601 PMID:19002567 More... NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929 		JBrowse link
G Gck glucokinase multiple interactions
increases expression
decreases expression		 ISO
EXP		 [ebselen co-treated with Glucose] results in increased activity of GCK protein; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of GCK mRNA; Glucose inhibits the reaction [Alloxan results in decreased expression of GCK mRNA]
Glucose results in increased expression of GCK mRNA
Glucose results in decreased expression of and affects the localization of GCK protein; Metformin inhibits the reaction [Glucose results in decreased expression of GCK mRNA]		 CTD PMID:12137914 PMID:23795780 PMID:24349266 PMID:31974165 PMID:37567420 NCBI chr14:80,785,060...80,829,842
Ensembl chr14:80,785,060...80,826,995 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions ISO
EXP		 [Glucose co-treated with gastrodin] affects the expression of GCLC mRNA CTD PMID:33764184 NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544 		JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit multiple interactions EXP
ISO		 [Glucose co-treated with gastrodin] affects the expression of GCLM mRNA CTD PMID:33764184 NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535 		JBrowse link
G Gcsam germinal center-associated, signaling and motility multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in increased expression of GCSAM mRNA CTD PMID:37567420 NCBI chr11:55,195,757...55,207,011
Ensembl chr11:55,196,712...55,206,992 		JBrowse link
G Gdap1l1 ganglioside-induced differentiation-associated protein 1-like 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GDAP1L1 mRNA CTD PMID:37567420 NCBI chr 3:152,110,225...152,129,693
Ensembl chr 3:152,110,253...152,128,711 		JBrowse link
G Gdf7 growth differentiation factor 7 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GDF7 mRNA CTD PMID:37567420 NCBI chr 6:31,171,495...31,182,484
Ensembl chr 6:31,178,119...31,182,447 		JBrowse link
G Gem GTP binding protein overexpressed in skeletal muscle increases expression ISO Glucose results in increased expression of GEM mRNA CTD PMID:17178593 NCBI chr 5:25,214,309...25,225,222
Ensembl chr 5:25,214,309...25,225,222 		JBrowse link
G Gh1 growth hormone 1 multiple interactions ISO GH1 protein promotes the reaction [Glucose results in increased phosphorylation of TBC1D4 protein]; Glucose inhibits the reaction [[Niacin results in decreased abundance of Fatty Acids, Nonesterified] which results in increased secretion of GH1 protein] CTD PMID:838844 PMID:21559284 NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078 		JBrowse link
G Ghrhr growth hormone releasing hormone receptor multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of GHRHR mRNA CTD PMID:37567420 NCBI chr 4:84,498,159...84,532,851
Ensembl chr 4:84,500,212...84,532,776 		JBrowse link
G Ghrl ghrelin and obestatin prepropeptide multiple interactions ISO [homoeriodictyol co-treated with Glucose] results in increased secretion of GHRL protein CTD PMID:28834253 NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621 		JBrowse link
G Gja1 gap junction protein, alpha 1 decreases expression
increases degradation
multiple interactions
increases expression		 ISO
EXP		 Glucose results in decreased expression of GJA1 protein
Glucose results in increased degradation of GJA1 protein
resveratrol inhibits the reaction [Glucose results in increased degradation of GJA1 protein]
Glucose results in increased expression of GJA1 mRNA
Glucose results in increased expression of GJA1 protein
Chloroquine inhibits the reaction [Resveratrol inhibits the reaction [Glucose results in increased expression of GJA1 protein]]; Chloroquine promotes the reaction [Glucose results in increased expression of GJA1 protein]; Resveratrol inhibits the reaction [Glucose results in increased expression of GJA1 protein]		 CTD PMID:17178593 PMID:20578705 PMID:28713934 NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582 		JBrowse link
G Gla galactosidase, alpha increases expression ISO Glucose results in increased expression of GLA mRNA CTD PMID:17178593 NCBI chr  X:97,769,227...97,780,646
Ensembl chr  X:97,768,996...97,780,664 		JBrowse link
G Glb1 galactosidase, beta 1 increases expression
increases activity
multiple interactions		 ISO
EXP		 Glucose results in increased expression of GLB1 protein
Glucose results in increased activity of GLB1 protein
NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein]; Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; resveratrol inhibits the reaction [Glucose results in increased expression of GLB1 protein]; Sirolimus inhibits the reaction [Glucose results in increased expression of GLB1 protein]; SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; SIRT1 protein promotes the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of GLB1 protein]]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Phytic Acid inhibits the reaction [Glucose results in increased expression of GLB1 protein]]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Fluorometholone inhibits the reaction [Glucose results in increased activity of GLB1 protein]]; CDKN1A protein affects the reaction [Glucose results in increased expression of GLB1 protein]; CDKN2A protein affects the reaction [Glucose results in increased expression of GLB1 protein]; Fluorometholone inhibits the reaction [Glucose results in increased activity of GLB1 protein]; Melatonin inhibits the reaction [Glucose results in increased expression of GLB1 protein]; Phytic Acid inhibits the reaction [Glucose results in increased expression of GLB1 protein]; SIRT3 protein inhibits the reaction [Glucose results in increased expression of GLB1 protein]		 CTD PMID:17075048 PMID:22561310 PMID:23494737 PMID:35264022 PMID:38000455 More... NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127 		JBrowse link
G Gli1 GLI family zinc finger 1 multiple interactions
increases expression		 ISO [Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA; [Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]; cyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]]; cyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein]]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of GLI1 mRNA]; polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased localization of GLI1 protein]
Glucose results in increased expression of GLI1 protein		 CTD PMID:27481074 PMID:33992720 NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251 		JBrowse link
G Gli2 GLI family zinc finger 2 affects localization
multiple interactions		 ISO Glucose affects the localization of GLI2 protein
[lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with 2,4-Dichlorophenoxyacetic Acid] results in decreased expression of GLI2 mRNA		 CTD PMID:33992720 PMID:37567420 NCBI chr13:29,946,882...30,163,589
Ensembl chr13:29,946,809...30,163,574 		JBrowse link
G Glipr1 GLI pathogenesis-related 1 multiple interactions ISO [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of GLIPR1 mRNA CTD PMID:37567420 NCBI chr 7:47,487,342...47,498,974
Ensembl chr 7:47,487,345...47,498,429 		JBrowse link
G Glo1 glyoxalase 1 multiple interactions
decreases expression		 ISO
EXP		 GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to HMGB1 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to S100A12 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [JUN protein binds to S100A8 promoter]]; GLO1 inhibits the reaction [Glucose promotes the reaction [RELA protein binds to AGER promoter]]; GLO1 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of AGER protein]; GLO1 inhibits the reaction [Glucose results in increased expression of and results in increased secretion of HMGB1 protein]; GLO1 inhibits the reaction [Glucose results in increased expression of HMGB1 mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A12 mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A8 mRNA]; GLO1 inhibits the reaction [Glucose results in increased expression of S100A8 protein]; SOD2 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]; UCP1 inhibits the reaction [Glucose results in decreased expression of GLO1 protein]
morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 mRNA]; morroniside inhibits the reaction [Glucose results in decreased expression of GLO1 protein]		 CTD PMID:19833897 PMID:32643284 NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649 		JBrowse link
G Glp1r glucagon-like peptide 1 receptor multiple interactions ISO
<